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Abstract
Public health initiatives include vaccination and screening efforts to reduce the burden of
disease. This study addressed colorectal cancer (CRC) screening behaviors of
accountable care organization (ACO) patients with different social determinants of health
and providers’ ability to comply with the Medicare Shared Savings Plan (MSSP) quality
measure ACO #19. This study followed the socioecological model and a cross-sectional
quantitative design to assess data from the MSSP public use file 2019 across three
manuscripts to expand on current literature. The purpose was to determine whether
patient behavior was the primary driver to improve healthcare quality. Study results
showed that performance rates increased in ACOs that had a greater number of patients.
ACOs with more non-White patients and more Medicaid patients were less successful
with CRC screening. Performance was highest when more patients were between 65-85
years of age as compared to patients under 65 or over 85 years old. The implications for
positive social change in this study include data for policy makers, health, and public
health care professionals to reduce disparities for CRC screening and incidence of CRC
among vulnerable populations. The data also support population health initiatives beyond
CRC-related illness.
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Part 1: Overview
Introduction
Health care delivery and public health have overlapping goals to improve health
outcomes in their communities through vaccination and screening. The paths toward
these goals are influenced by factors like policies, funding sources, and external demands
that guide community-based organizations’ and health care and public health
organizations’ decisions (Cunningham et al., 2020). To address rising healthcare costs in
the United States (Shrank et al., 2019) as well as significant disparities in health
outcomes across the population (Foo et al., 2017), public, community, and clinical health
professionals in several communities have partnered to form organizations designed to
improve public health by addressing social determinants of health and influencing
individual behavior (Bachrach et al., 2016; Noble et al., 2014). For example, the Institute
of Healthcare Improvement’s Quadruple Aim outlined a framework to improve health
outcomes, lower healthcare costs, improve patient experience, and improve clinician
satisfaction (Wagner et al., 2018). Experimental alternative payment delivery models
(APM) were created with varying success to influence components of the Quadruple Aim
(Noble et al., 2014).
Additionally, population engagement can lead to behaviors that result in healthier
outcomes, which may also reduce the overall cost of care (Grand et al., 2014; Simmons et
al., 2014). Two population-based behaviors intended to reduce the burden of disease
include vaccinations and screenings (Siewert et al., 2020). Over 34,000 Americans died
from influenza during the 2018–2019 influenza season, which included nearly 500,000
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hospitalizations and an estimated 35.5 million people who became sick; however, the
general rate of behavior adoption for influenza vaccinations in the United States is less
than 50%, with rates among people aged 65 year and older approximately 65% (Centers
for Disease Control and Prevention [CDC], 2019). But physicians are often the first line
of defense to promote the behaviors that influence public health (Redwood et al., 2016).
Another example of population-based behavior is colon cancer screening. In
2016, colorectal cancer (CRC) was the third leading cancer diagnosed for U.S. citizens,
excluding skin cancers, with an estimated 40,000 deaths attributed to colon cancer
(Bachman et al., 2018). Individuals who are overweight, use alcohol, smoke, practice
risky sex, and are physically inactive are at higher risk of CRC (Bachman et al., 2018).
These risks are influenced by individuals’ behavior; however, CRC screening can provide
early identification of CRC and improve health outcomes (Bachman et al., 2018). But
there are significant differences in CRC screening rates across, racial, and
sociodemographic populations (Bachman et al., 2018). Cancer screening rates have also
declined due to the COVID-19 pandemic especially for minority populations, which is
expected to lead to increase cancer for all populations (Carethers et al., 2020). Before the
pandemic, physicians enrolled in accountable care organizations (ACOs) were measured
on the success rate of CRC screening for their patients through the performance measure
ACO #19 of the standards of the Medicare Shared Savings Plan (MSSP) for CRC
Screening (Smith et al., 2019). Medicare recognized four methods of CRC screening that
vary in complexity and invasiveness: fecal immunochemical test, fecal occult blood test,
multitarget stool DNA test and colonoscopy (Smith et al., 2019).
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Problem
Health care delivery and public health have overlapping efforts like health
screening activities to lower the burden of disease (Cunningham et al., 2020). Though
patient behavior is the key to improve quality and health outcomes, there are barriers to
influence individual behavior (Morge et al., 2019). Moreover, there are disparities in
compliance among people with health behavior recommendations based on factors like
age, gender, insurance coverage, and the size of their providers’ practices (Kiviniemi et
al., 2018; Manteuffel et al., 2014). Data on the patient experience are abundant and
available through performance reporting, from sources like the Centers for Medicare and
Medicaid Services (CMS, n.d.), and patient perspectives toward patient engagement are
well documented in the literature (Rowland et al., 2017). However, provider success and
strategies to engage community members attributed to their APMs has not been
comprehensively explored (Andrealli et al., 2018; Bekmuratova et al., 2019; Berenson et
al., 2016; Chen et al., 2016). Thus, there is an inability to replicate best practices for
population engagement, which could improve health outcomes, participant experiences,
lower costs, and improve job satisfaction.
Contribution to Social Change
Partnerships between community-based organizations, health care delivery, and
public health organizations improve public health outcomes (Cunningham et al., 2020).
My study addressed the gap in research by focusing on providers’ abilities to influence
APM participant behavior. The results may contribute to positive social change by
providing meaningful data to public health partnerships that impact community health
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outcomes. Thus, my study could improve the ability to influence the behaviors and health
outcomes of the community members they serve.
Background
ACOs are one of the APMs designed to alter the reimbursement of healthcare
services from a traditional fee-for-service structure to a value-based care model. The
initial performance under the Medicare ACO model reduced healthcare expenditures
within the attributed population base when compared to traditional Medicare fee-forservice beneficiaries (Nywelde et al., 2015). CMS measures ACO providers across four
domains: care coordination, patient safety, patient experience, and preventative health
(Mod et al., 2018). Providers are rewarded for the decreased cost of patient care and
achievement of various quality metrics outlined in their ACO contracts. Studies have
shown that many healthcare providers including those in underserved areas saw ACOs as
a means to achieve greater quality while improving population health (Bekmuratova et
al., 2019; Berenson et al., 2016). Furthermore, some organizations believed that
improving health outcomes outweighed financial incentives (Phipps-Taylor & Shortell,
2016). Conversely, some providers avoided ACO membership because they did not have
the infrastructures or collaborative relationships in place to succeed (Bekmuratova et al.,
2019), though there has been growing emphasis on preventative care and more
collaboration between healthcare providers and traditional public health organizations
(Ingram et al., 2015). This is particularly true for cancer prevention initiatives (Basch et
al., 2016).
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CRC is a leading cause of death in the United States and can be reduced with
early detection (Lloyd, 2016). However, almost 25% of adults between 76 and 84 did not
meet the U.S. Preventative Services Task Force recommendations for CRC screening
before the advent of Medicare ACOs. Furthermore, the early rates of provider
recommendations for appropriate CRC screening were very low (Klabunde et al., 2015).
Patient behavior may be the primary driver of improving screening rates, as there
has been association between patient behavior, the patient–provider relationship, and
adherence to suggested clinical guidelines (Gudzune et al., 2014; Manteuffel et al., 2014).
Several studies offered anecdotal patient interventions that increased patient success
(Nathan et al., 2016; Singal et al., 2017; Slyne et al., 2017). Moreover, culturally
competent approaches are important (Alsayid et al., 2019; Brittain & Murphy, 2015;
Chen et al., 2016). Studies also documented perceived barriers as articulated by the
provider and provider characteristics that influenced their decision making and ability to
succeed (Mastrokostas et al., 2018; Wang et al., 2018). This included the ability to verify
the patient’s CRC status or availability of specialists (Mastrokostas et al., 2018). For
example, a provider recommendation is a primary influence on whether patients
participate in CRC screenings (Bian et al., 2016; Bromley et al., 2015), which has been
recommended more with health information technology to help alert a patient’s CRC risk
(Kim et al., 2017; Mankaney et al., 2019). Additionally, it is important to implement
systems that support patient engagement activities that influence behavior like
motivational interviewing, goal setting, and shared decision making (Mishra et al., 2018).
However, some providers have lacked the depth of understanding and practice to
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implement these concepts in a meaningful way, and some provider experiences with
difficult patients have led to feeling anxious, frustrated, and uncertain with little
preparation for how to handle difficult patients (Shapiro et all, 2018).
Ineffective communication and perceived provider uncertainty may also influence
patient decision-making process (Beverly et al., 2016). Patients’ expectations of
providers based on provider characteristics like age, race, and gender also influence their
decisions (Alspach, 2018; Mast & Kadji, 2018). For example, uncertainty among female
providers was seen as a form of truthfulness, whereas the trait generated mistrust for male
providers (Mast & Kadji, 2018). Trust has also been demonstrated to be a contributing
factor behind non-compliance of CRC screening for Hispanic patients (Hong et al.,
2018).
Fear is another influencer of compliance for all patients, especially for African
American patients (Basch et al., 2016; Bromley et al., 2015; Hall et al., 2016; Kiviniemi,
Klasko-Foster et al., 2018; Mastrokostas et al., 2018). Fear presents in the form of fear of
the findings from the procedure as well as fear of the procedure itself (Bromley et al.,
2015). Colonoscopy is the most popular form of CRC screening, which includes multiple
steps like scheduling, bowel preparation, sedation and the procedure itself; some of which
contain multiple levels of compliance (Powers & Keohane, 2018). Strategies such as
enhanced written education, media campaigns, and videos improve compliance with
bowel preparations (Andrealli et al., 2018; Cole et al., 2019; Essink-Bot et al., 2016).
However, they have been less effective to improve patient health literacy and compliance
for completing a colonoscopy (Clark et al., 2017; Enard et al., 2015; Mishra et al., 2018).
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Further, studies suggest CRC compliance varies with the type of test offered,
which could impact how providers achieve patient compliance with their
recommendations (Alsayid et al., 2019; Basch et al., 2016; Bian et al., 2016; Brenner &
Chen, 2017; Bromley et al., 2015; Chambers et al., 2016). Medicare recognizes four
methods of CRC screening to achieve compliance with the ACO #19 measure:
colonoscopy, DNA, stool testing, and fecal occult blood test (Prince et al., 2017).
Key Variables and Alignment
I explored the preventative quality performance measure (ACO #19) for CRC
screening under MSSP ACO guidelines as the dependent variable across all three
manuscripts. I explored how the independent variables of patient demographic
characteristics race, age, gender, and insurance coverage predict performance. I also
examined the relationship between practice size (i.e., size of attribution and number of
primary care providers) and ACO #19. Manuscript 1 quantified overall performance of
ACO #19 based on practice size followed by the influence of patient characteristics in
Manuscript 2 and insurance coverage in Manuscript 3.
Provider performance continues to be assessed by CMS (Preston et al., 2018).
Most high performing ACOs have had positive collaboration with a hospital, established
physicians focused on performance improvement, sophisticated information technology
infrastructure, care coordinators, physician feedback, and an effective physician practice
before joining the ACO (D’aunno et al., 2018). However, providers who had low quality
metric measures before starting their ACO agreement had more room to improve and
thus more to gain from their agreements (Green et al., 2015). Moreover, this range for
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improvement narrowed in subsequent years once the provider’s performance level
reached that of their peers. Assessments on the performance of the first ACOs also
showed an increase in CRC screening for patients 65 years or older when compared to
non-ACO patients or the start of the ACO model (Preston et al., 2018). Studies have also
indicated that strategies to improve CRC screening rates include patient reminder
programs (Gauci et al., 2018; Grimes et al., 2019), patient outreach programs (Singal et
al., 2017), patient financial incentives (Mehta et al., 2019), embedded care coordinators
and various patient decision aids (Reuland et al., 2017).
Despite these strategies to increase engagement, significant disparities for
screening rates have been found between White and non-White ACO members (Bromley
et al., 2015). Additionally, the trend to improve quality measures has not been the case
for ACOs in underserved communities or those with a higher number of minority patients
(Bromley et al., 2015; Lewis et al., 2017). Yet provider payments continue to be the
direct result of their ability to meet established benchmarks, including those for CRC
screenings, which are ultimately based on patient behavior.
Additionally, communication is a strategy often cited for improved patient
outcomes (Ahmed & Bates, 2016; Alsayid et al., 2019; Beverly et al., 2016; Bientzle et
al., 2015), but there are racial disparities in patient–physician communication (Foo et al.,
2017). Physician’s race has predicted the amount of time the physician spent talking with
patients and the level of empathy they displayed. Research has also reported racial,
socioeconomic, and gender bias among healthcare providers when making medical
decisions (Williams, 2015), though some studies have found no relation to these
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characteristics and provider decisions (Haider et al., 2015). Regardless, tailored
communication based on patient characteristics can improve communication and patient
engagement (Hagiwara et al., 2018), and the disconnect for cancer screening between the
patient and provider has been compounded by the lack of provider continuity for minority
patients (Arnold et al., 2017).
Socioeconomic status is also a patient characteristic and determinant of CRC
screening completion (Farrukh & Mayberry, 2019). Some ACO populations include
underserved and vulnerable patients who are covered by Medicaid in addition to their
Medicare coverage (Powers & Keohane, 2018). But studies have suggested that lower
socioeconomic patients and Medicaid patients experienced bias when they pursued CRC
screening (Davis et al., 2017). For example, Nymo et al. (2018) reported that patients
with lower income experienced longer wait times when they scheduled CRC screening
procedures, whereas patients with higher income were prioritized to enhance their patient
experience and satisfaction. Though other studies have suggested Medicaid patients
received more opportunities for CRC screening as care coordination improved for dual
eligible patients (Craver et al., 2018), providers must be aware of both intentional and
unintended bias when working with patients from different cultures and socioeconomic
groups (Alspach, 2018).
Conceptual Framework
The socioecological model (SEM) guided my cross-sectional quantitative study in
assessing data from the MSSP 2018 public use file (PUF). Under the SEM, provider
performance is affected by factors that influence both their decision making and their
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effectiveness to influence patient behavior (Rabarison et al., 2013). SEM posits five
categorical levels that affect behavior change: the individual, interpersonal,
organizational, community/environment, and society/policy levels (Lampard et al., 2013).
Though the factors of the SEM are hierarchical, they are also integrated, and a change in
one area could impact others (Coreil, 2009).
The positivist ontology also guided my study. Positivism implies that there is a
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment
through a PUF; thus, these results reflect a single truth of their performance. In
Manuscript 1 I determined how provider size correlates to ACO #19 measure attainment.
In Manuscript 2 I determined how patients’ race, age, and gender predicted providers’
ACO #19 measure attainment. In Manuscript 3 I determined how insurance coverage
predicted how effective providers were at achieving ACO #19 measure attainment. The
findings for each manuscript were the source of truth under the positivist ontology for my
study.
Overview of the Manuscripts
My study provides a more comprehensive assessment of the physicians’ ability to
influence patient behavior than quantitative data like those from CMS. The U.S. health
care system is unsustainable with many health disparities across the population (Foo et
al., 2017; Shrank et al., 2019). Thus, there is need to lower health care costs by
influencing patient behavior protects vulnerable U.S. citizens at risk if the U.S. healthcare
system collapses. A social justice perspective also applies to my study if findings can
supplement previous research that shows differences in provider performance or
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experiences correlating to race, gender, or socioeconomic status of their patients (Foo et
al., 2017). The manuscripts were tied by the overarching theme of physicians’ influence
on patient behavior. The manuscripts were framed as parallel projects where data
collection was captured at the same time, then reported based on the research goals of
each manuscript.
Manuscript 1

Problem
Health care delivery and public health professionals form partnerships to reduce
the burden of disease and are influenced by policies, healthcare costs, funding sources,
and external demand (Cunningham et al., 2020). The MSSP ACO is an APM designed to
curb cost and improve patient outcomes for colon cancer among other disease measures.
Since CRC is a leading cause of death in the United States (Loyd, 2016), more research is
needed to determine the impact of MSSP ACO providers on CRC screening.

Research Question
Based on the performance measures of the MSSP, what is the relationship
between practice size and compliance with MSSP performance measure ACO #19?
H0: There are no statistically significant differences in the compliance of MSSP
performance measure ACO #19 based on practice size.
Ha: There are statistically significant differences in the compliance of MSSP

performance measure ACO #19 based on practice size.
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Nature of the Study
My cross-sectional quantitative study employed the MSSP PUF for secondary
data analysis to examine the association between the independent variable practice size
and the dependent variable of compliance with MSSP performance measure ACO #19.
The 2019 MSSP PUF was used as a data source.

Limitations, Challenges, and/or Barriers
The MSSP PUF is a secondary data set and has a 1-year delay in reporting. A
limitation to using the MSSP PUF file is that all quantitative data are restricted to the
variables within the data set. For example, the Preventative Health Domain represents
provider influence on patient behavior. These include public health initiatives presented
by Healthy People 2020 like getting a flu shot during flu season, a plan to reduce
unhealthy body weight, receiving help/information for tobacco use, getting a pneumonia
vaccine, and screening for CRC (CMS, n.d.). My study examined ACO #19 or colon
cancer screening, which is the most complex measure of behavior change captured by
MSSP reporting (CMS, 2017). However, the MSSP PUF database provided an adequate
sample size for successful compliance with ACO #19 to meet the statistical requirements
of my study.

Other Information
My study assessed health professional’s influence on complex patient behavior.
The MSSP ACO PUF contains physician performance against 32 measures across four
domains (CMS, n.d.). The results were the official CMS findings and used to pay
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provider incentives (Noble et al., 2014). Therefore, these measures were valid
representations of physician performance.
Manuscript 2

Problem
CRC is a leading cause of death in the United States, with significant disparities
between population groups (Loyd, 2016). The MSSP ACO is an APM designed to curb
cost, improve patient outcomes for colon cancer and other disease measures. But more
research is needed to determine the impact of MSSP ACOs on CRC screening for
different types of patients.

Research Question
Based on the performance measures of the MSSP, what is the relationship
between the ACO population's demographics race, age, and gender and compliance with
MSSP performance measure ACO #19?
H0: There are no statistically significant differences in compliance with MSSP
performance measure ACO #19 based on the ACO population's demographics, race, age,
and gender.
Ha: There are statistically significant differences in compliance with MSSP

performance measure ACO #19 based on the ACO population's demographics, race, age,
and gender.

Nature of the Study
The nature of Manuscript 2 was a cross-sectional quantitative study and employed
the MSSP PUF for secondary data analysis to examine the association between the
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independent variables race, age, and gender and the dependent variable of compliance
with MSSP performance measure ACO #19. Again, the 2019 MSSP PUF was the
primary data source.

Limitations, Challenges, and/or Barriers
The MSSP PUF is a secondary data set and has a 1-year delay in reporting. A
limitation to using the MSSP PUF file is that all quantitative data are restricted to the
variables within the data set. For example, the Preventative Health Domain represents
provider influence on patient behavior. These include public health initiatives presented
by Healthy People 2020 like getting a flu shot during flu season, a plan to reduce
unhealthy body weight, receiving help/information for tobacco use, getting a pneumonia
vaccine, and screening for CRC (CMS, n.d.). My study examined ACO #19 or colon
cancer screening, which is the most complex measure of behavior change captured by
MSSP reporting (CMS, 2017). However, the MSSP PUF database provided an adequate
sample size for successful compliance with ACO #19 to meet the statistical requirements
of my study.
Manuscript 3

Problem
CRC is a leading cause of death in the United States, with significant disparities
between population groups (Loyd, 2016). The MSSP ACO is an APM designed to curb
cost, improve patient outcomes for colon cancer and other quality measures. Studies
suggest bias and disparities for patients based on sociodemographic status (Foo et al.,
2017). Furthermore, research has demonstrated disparities in CRC screening based on

15
insurance type (Kiviniemi et al., 2018). Thus, ore research is needed to determine the
impact of MSSP ACO on CRC screening for patients with different types of insurance.

Research Question
Based on the performance measures of the MSSP, what is the relationship
between insurance coverage and compliance with MSSP performance measure ACO
#19?
H0: There are no statistically significant differences in compliance with MSSP
performance measure ACO #19 based on insurance coverage.
Ha: There are statistically significant differences in compliance with MSSP

performance measure ACO #19 based on insurance coverage.

Nature of the Study
The nature of Manuscript 3 was a cross-sectional quantitative study and employed
the MSSP PUF for secondary data analysis to examine the association between the
independent variable insurance coverage and the dependent variable of compliance with
MSSP performance measure ACO #19. Again, the primary source of data was the 2019
MSSP PUF.

Limitations, Challenges, and/or Barriers
The MSSP PUF is a secondary data set and has a 1-year delay in reporting. A
limitation to using the MSSP PUF file is that all quantitative data are restricted to the
variables within the data set. For example, the Preventative Health Domain represents
provider influence on patient behavior. These include public health initiatives presented
by Healthy People 2020 like getting a flu shot during flu season, a plan to reduce
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unhealthy body weight, receiving help/information for tobacco use, getting a pneumonia
vaccine, and screening for CRC (CMS, n.d.). My study examined ACO #19 or colon
cancer screening, which is the most complex measure of behavior change captured by
MSSP reporting (CMS, 2017). However, the MSSP PUF database provided an adequate
sample size for successful compliance with ACO #19 to meet the statistical requirements
of my study.
Significance
Each manuscript provided data that may improve the strategies public health and
health care delivery professionals use to reduce the burden of CRC. I addressed a gap in
research in Manuscript 1 to show how ACOs with more patients were more compliant
with CRC screening recommendations, though results indicated that more non-White
patients were less compliant with screenings and the number of providers in an ACO did
not influence compliance with the measure. In Manuscript 2, I expanded on current
literature on disparities in CRC screening based on race, age, and gender. I found that
ACOs with more Black patients were less compliant with ACO #19. I also demonstrated
that ACOs with patients between the age of 65–85 more likely meet CRC
recommendations. Lastly, I addressed a gap in research in manuscript 3 to show ACO
#19 performance decreases as the number of Medicaid patients in the population
increases.
My research can help decrease disparities for CRC screening and incidence of
CRC among vulnerable populations. Furthermore, the data may help public health
professionals, community advocates, and healthcare providers drive behavior adoption
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for their community members. Lastly, my study provides a foundation for population
health initiatives beyond CRC related illness.
Policy
Alternative practice models incorporate value-based care methodologies that
move health care away from a costly volume-driven fee-for-service structure toward
quality incentivized population health management frameworks, many of which hinge on
partnerships between primary care physicians and public health organizations (Nywelde
et al., 2015). Manuscript 1 applies to policies that govern the minimum number of
patients in ACOs that might influence CRC screening rates for elderly patients.
Furthermore, the results can influence policy related to provider patient ratios.
Manuscript 2 applies to policies that support health and wellness initiatives in
communities of color and patients aged 65 year and older. Manuscript 3 can influence
policy related to insurance coverage particularly for Medicaid and Medicare patients,
applying toward additional policies for lower socioeconomic populations as to the
eligibility for these services and the scope of benefits they receive.
Overall, my study will influence policy by outlining the success, shortcomings,
and possible rationale for health outcomes. This could provide policymakers a unique
perspective to maintain or improve the MSSP ACO program or other partnership
approach programs between community organizations, healthcare delivery, and public
health organizations.
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Social Change
Each manuscript promotes positive social change by providing meaningful data to
the public health organization and health care provider partnerships engaged in
transforming healthcare from a transactional delivery system to an evidence-based system
of value (Berenson et al., 2016). Manuscript 1 may improve public health and healthcare
professionals’ ability to influence the behaviors and health outcomes of the community
members they serve and provide an evidence-based approach to determining the structure
or model for programs designed to improve health outcomes. Manuscript 2 can help
decrease the prevalence and disparities of CRC and by doing so reduce the economic and
quality of life burden for individuals and communities suffering from the disease.
Moreover, Manuscripts 2 and 3 may help to reduce disparities for CRC screening and
incidence of CRC among vulnerable populations.
Overall, my study provides a foundation for population health initiatives beyond
CRC related illness, thus improving the well-being of communities and increase public
health emergency preparedness. Therefore, my study can improve public health and
healthcare professionals’ ability to influence the behaviors and health outcomes of the
community members they serve. My findings can guide both public health and healthcare
provider leaders on ways to train professionals better, reduce frustration, improve
success, and achieve higher levels of satisfaction in their work both in routine
interventions and public health emergencies.
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Summary
Each manuscript explores Medicare’s MSSP ACOs as one of the interventions
initiated by CMS to promote collaboration, better health outcomes, and lower costs of
care for patients 65 years or older (Noble et al., 2014). One component of ACOs includes
preventative care (Noble et al., 2014). Public health professional and healthcare providers
have mutual interest to increase appropriate CRC screening rates to reduce the incidence,
economic burden, and mortality from CRC (Bachman et al., 2018; Bachrach et al., 2016).
But studies suggest disparities among the population for age, sex, and ethnicity (Bachman
et al., 2018). Studies also show an ongoing variance of care delivered to people with
different levels and type of insurance coverage (Kiviniemi et al., 2018; Manteuffel et al.,
2014). Thus, I assessed the effectiveness of meeting CRC screening guidelines based on
provider size, patient characteristics variables and patient insurance type for ACO #19
measures for CRC screening.
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Part 2: Manuscripts
The Relationship Between Advanced Payment Model Providers and Patient
Behavior: Practice Size and Provider Influence on Patient Behavior

Harry Petaway, MPA

Walden University

Objective: This study assesses the preventative quality performance measure (ACO #19)
for colon cancer screening under Medicare Shared Savings Plan ACO guidelines. I
quantified the overall performance of ACO #19 based on provider practice size.

Methods: A cross-sectional quantitative study was conducted for organizations who
participate as a Medicare Shared Savings Plan Accountable Care Organization. The
research included secondary data analysis of the 2019 Medicare Shared Savings Plan
PUF on quality performance.
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Outlet for Manuscript
The American Journal of Public Health (AJPH) is the intended journal for this
manuscript (https://ajph.aphapublications.org/). The initial submission requires a title
page with the manuscript title, author name and affiliations, and full abstract and the
manuscript with author and university information removed. In addition, the manuscript
should contain the following elements:
a. Title and abstract
b. page numbers
c. numbered lines (in Word, > Page Setup > Line Numbers > Continuous)
throughout the text of the manuscript;
d. 1.5 or double spacing with a font size of 12
e. tables and figures embedded at the end of the manuscript, OR uploaded as
separate files
Submission also requires a cover letter with concise text (maximum 150 words) that
provides a description of what the paper adds to the knowledge on the topic, especially in
respect to material previously published in the journal and elsewhere; includes the public
health importance of the paper; and highlights the main message of the paper in one
sentence. With the exception of history essays, all AJPH articles follow the AMA Manual
of Style, 10th Edition. Substantive notes and footnotes are not permitted.
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Abstract
Public health efforts include vaccination and screening initiatives to reduce the burden of
disease. This study focused on colorectal cancer (CRC) screening behaviors of
accountable care organization (ACO) patients of different population sizes. It addressed
performance among organizations based on the number of primary care providers in the
ACO. This study used the socioecological model and a cross-sectional quantitative design
to assess data from the Medicare Shared Savings Plan public use file 2019 to expand on
current literature that determined patient behavior was the primary driver to improve
healthcare quality and reduce costs. ACOs with more patients generally had better CRC
screening compliance. However, the results showed that ACOs with more non-White
patients were less successful. Results also indicated that participating in an ACO may
mediate the constraints of smaller provider practices to improve patient care, though the
results found that lesser numbers of primary care providers in an ACO did not negatively
influence performance. The implications for positive social change include data to reduce
disparities for CRC screening and incidence of CRC among vulnerable populations and
provide a foundation for population health initiatives and policies beyond CRC related
illness, which can improve the well-being of communities and increase public health
emergency preparedness.
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Introduction
Healthcare costs in the United States are rising at an unsustainable rate and
include significant disparities in health outcomes that have been attributed to social
determinants of health (Foo et al., 2017; Noble et al., 2014). Physicians and public health
professionals lead much of the effort to manage this public health crisis (Ingram et al.,
2015). As a result, public health agencies and clinical health organizations have formed
partnerships in several communities to form new public healthcare delivery models
(Noble et al., 2014). These partnerships were designed to improve health by influencing
individual behavior and addressing social determinants of health (Bachrach et al., 2016).
For example, the Institute of Healthcare Improvement’s Quadruple Aim outlined a
framework to improve health outcomes, lower healthcare costs, improve patient
experience, and improve clinician satisfaction (Wagner et al., 2018). This contributed to
the development of experimental alternative payment delivery models (APMs) to achieve
components of the Quadruple Aim, but these new designs had varying degrees of success
(Noble et al., 2014). Studies have shown that population engagement was essential to
guide community members toward behaviors that lead to healthier outcomes, which
could reduce the overall cost of care (Grand et al., 2014); however, there was little
evidence of which strategies were most successful at influencing the population’s
behavior.
Problem
Physicians have indicated that patient behavior is the key to improve health
quality and outcomes, yet many have found it difficult to influence individual behavior
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(Hibbard et al., 2015). Moreover, researchers have found disparities in patient
compliance with health behavior recommendations (Kiviniemi et al., 2018; Manteuffel et
al., 2014) linked to patient characteristics and provider variables like the size of provider
practices (Kiviniemi et al., 2018; Manteuffel et al., 2014). Data on the patient experience
are captured through performance reporting by the Centers for Medicare and Medicaid
Services (CMS, n.d.), and patient perspectives toward patient engagement have been well
documented in the literature (Rowland et al., 2017). However, provider experiences,
perceptions, success, and strategies to engage community members attributed to their
APMs are not represented in detail in previous research (Andrealli et al., 2018;
Bekmuratova et al., 2019; Berenson et al., 2016; Chen et al., 2016). Thus, there is an
inability to replicate the best practices for population engagement that improve
participant experiences, job satisfaction, health outcomes, and lower costs. I addressed
this gap in research by focusing on the relationship of practice size and providers’
influence on APM patient behavior. I explored the preventative quality performance
measure for colon cancer screening ACO #19 for the Medicare Shared Savings Plan
(MSSP) accountable care organization (ACO) guidelines.
Significance of the Study
APMs introduced patient engagement initiatives to lower healthcare costs in the
United States with different levels of success (Noble et al., 2014). Extensive quantitative
data on APM quality are captured by CMS performance reports (CMS, n.d.). The
literature, however, has not shown evidence on why physicians were successful at
influencing patient behavior. For example, Smiddy et al. (2015) showed that financial
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incentives increased the number of focus groups in the United Kingdom but found little
impact on the quality of care delivered. In the current study, I explored provider
experiences with managing patient populations of different sizes and ethnicities to
explain to what degree they affect patient behavior compared to the measures that
determine their payments and further explain the impact of provider collaboration within
advanced payment models on their outcomes. My study showed that ACOs with larger
patient populations were more compliant with CRC screening recommendations, and
ACOs with more non-White patients were less compliant with screenings. Further, the
number of providers in an ACO did not influence compliance with the measure.

Relevant Contribution to the Body of Knowledge
This manuscript is the first of three manuscripts to a cross-sectional quantitative
study to explore the preventative quality performance for colon cancer screening under
MSSP ACO guidelines. My broader study explores how patient demographic
characteristics race, age, gender, and insurance coverage predict performance. The
purpose of my study was to assess the relationship between practice size and provider
effectiveness at influencing patient behavior as measured by the compliance of MSSP
performance measure ACO #19. This manuscript fills a gap in research by focusing on
provider practice characteristics. My cross-sectional study provides a more
comprehensive assessment of physician influence on patient behavior than studies like
those from CMS.
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Framework
The socioecological model (SEM) guided my cross-sectional quantitative study in
assessing data from the MSSP public use file (PUF). Under the SEM, provider
performance is affected by factors that influence both their decision making and their
effectiveness to change patient behavior (Rabarison et al., 2013). SEM posits five
categorical levels which affect behavior change: the individual, interpersonal,
organizational, community/environment, and society/policy levels (Lampard et al., 2013).
Though the factors of the SEM are hierarchical, they are also integrated, and a change in
one area could impact others (Coreil, 2009).
The positivist ontology also guided my study. Positivism implies that there is a
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment
through a PUF; thus, these results reflect a single truth of their performance. I showed
how the number of providers in an ACO and the size of the patient population correlate to
their ACO #19 measure attainment. These findings are the source of truth under the
positivist ontology for my study. Additionally, the definition of “provider success” is
precise and supports a quantitative ontology of positivism where there is one true reality
(Burkholder et al., 2016). Positivism guided my cross-sectional quantitative study to
answer the question “How effective were providers at influencing patient behavior based
on the performance measure ACO #19 of the Medicaid Shared Savings Plan?” I analyzed
archival data from the CMS to support the positivist approach to my research question
(Burkholder et al., 2016).
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My study is influenced by multiple contexts. The personal contexts for my study
include my knowledge and experience with advance payment models and patient
engagement. The social contexts include CMS guidelines, the fluidity of US healthcare
policy, political climate, geographic locations, and local healthcare delivery priorities.
Lastly, interpersonal contexts include Walden University dissertation committee
representatives.
Background
The first ACOs were created to reduce preventable health problems amid cost
constraints have varied in United States (Noble et al., 2014). Hibbard et al. (2015)
documented that compensation from similar models used in other countries influenced
physician opinions on the importance of patient behavior. They further provided evidence
that patient behavior was the primary driver of improving quality (Hibbard et al., 2015).
Other studies showed that improvements in patient engagement lead to better health
outcomes (Simmons et al., 2014; Grand et al., 2014)), and that both independent
healthcare professionals and healthcare organizations committed significant investments
to improve outcomes, lower costs and improve patient experiences (Nwelde et al., 2015).
Physicians in the United States agreed that patient behavior was the key
determinant to improve quality and outcomes, yet, many found frustration when trying to
influence individual behavior (Hibbard et al., 2015). While many providers perceived
their role in the community and within population health as “medicine-based”; a growing
emphasis on preventative care and the diverse characteristics of their patient attribution
fostered better collaboration between healthcare providers and traditional public health
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organizations (Ingram et al., 2015). This was particularly true for mutual objectives such
as cancer prevention (Basch et al., 2016).
Research showed that differences in the structures of provider practices
influenced their capacities to provide care and influence patient behavior (Casalino &
Chenven, 2017; Casalino et al., 2013; Kim et al., 2017; Pineault et al., 2016). These
included financial stability, training, staff, and other key resources like health information
technology (Casalino & Chenven, 2017; Casalino et al., 2013; Kim et al., 2017).
However, researchers have suggested that some providers believed collaborative
partnerships might mediate resource constraints tied to their practice size and geographic
designation (Kim et al., 2017). Other evidence showed that the collective patient
population was based partly on their practice size and was a key determinant of their
success with CMS quality measurements (Greene et al., 2015).
ACOs were designed to shift the focus of healthcare services from a traditional
fee for service structure to a value-based care model tied to better health outcomes (Noble
et al., 2014). Nyweide et al. (2015) proved the initial performance under the Medicare
ACO model lowered costs when compared to traditional Medicare fee-for-service
beneficiaries. The CMS measures ACO providers across four domains, which include
care coordination, patient safety, patient experience, and preventative health (Mod et al.,
2018). Providers are paid more for achieving multiple quality metrics outlined in their
ACO contracts and for the providing care at a lower cost. as well as (Noble et al., 2014).
Studies showed that many healthcare providers including those in underserved areas saw
ACOs as a means to provide greater quality while improving population health
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(Bekmuratova et al., 2019; Berenson et al., 2016). Furthermore, some organizations
perceived the goal to improve patient care, simply outweighed any financial rewards they
may receive (Phipps-Taylor & Shortell, 2016). Conversely, other evidence showed that
providers avoided ACO membership as they did not have the infrastructures or
collaborative relationships in place to succeed (Bekmuratova et al.).
Colorectal cancer (CRC) is a leading cause of death in the United States (Lloyd,
2016). The Centers for Disease Control and Prevention estimated over 40,000 deaths
attributed to colon cancer in 2016 (Bachman et al., 2018). CRC screening is a key public
health focus and measurement of ACOs. The risk of CRC mortality can be reduced with
early detection (Lloyd, 2016). Focused efforts to increase CRC screening led to an
overall reduction of CRC related deaths in the last decade; yet, several disparities
continue to exist across, socioeconomic and racial/ethnic boundaries (Bromley, May,
Federer, Spiegel, & Van Oijen, 2015). Klabunde et al. (2015) reported that almost 25% of
adults between 76 and 84 did not meet the U.S. Preventative Services Task Force
recommendations for CRC screening before the advent of Medicare ACOs. Furthermore,
the incidence of provider recommendations for appropriate CRC screening was very low
(Klabunde et al., 2015). This problem was further compounded with racial disparities for
non-White patients who were less likely to complete screening and had an increased
prevalence of adverse health outcomes as a result (Klabunde et al.).
A growing body of evidence also documented disproportionate racial and
socioeconomic disparities and highlighted the diverse needs to motivate patients toward
compliance (Ashktorab et al., 2017; Bromley et al., 2015; Burnett-Hartman et al., 2016;
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Chablani et al., 2017). Several studies offered anecdotal patient interventions which
increased patient success (Nathan et al., 2016; Singal et al., 2017; Slyne et al., 2017).
Studies which focused on patient experience suggested culturally competent approaches
based on different patient characteristics (Alsayid et al., 2019; Brittain & Murphy, 2015;
Chen et al., 2016). Research also documented provider perceptions of barriers and
provider characteristics that influenced their decision making and success (Mastrokostas
et al., 2018; Wang et al., 2018). These included the basic ability to verify their patients’
correct CRC status and the clinician’s ability to confer with specialists (Mastrokostas et
al., 2018).
For example, a provider recommendation was a primary influence on whether
patients of all demographic groups participated in CRC screenings (Bian et al., 2016;
Bromley et al., 2015). Some studies showed that health information technologies that
shared patient information, alerted providers to the patient’s CRC risk and screening
status nudged providers to provide CRC screening recommendations (Kim et al., 2017b;
Mankaney et al., 2019). Additionally, other studies reiterated the importance of Patient
Behavior on quality performance and the need to implement systems to support patient
engagement activities that influence behavior (Mishra et al., 2018). These included the
concepts of, motivational interviewing, goal setting, and shared decision making (Mishra
et al., 2018). However, a study conducted by Mishra and colleagues (2018) showed that
while providers were aware of these concepts, they lacked the depth of understanding and
practice to implement them in a meaningful way. Shapiro et al. (2018) further described
provider experiences with tough to manage patients in which providers described
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themselves as anxious, frustrated, and uncertain with little preparation for how to handle
difficult patients.
Ineffective communication and perceived provider uncertainty may influence
patient decision-making process (Beverly et al., 2016). This can also be confounded by
patients' expectations based on the provider’s characteristics such as age, race, gender and
experience (Alspach, 2018; Mast & Kadji, 2018).Fear was another influencer of
compliance for all patients, but particularly among non-White patients (Basch et al.,
2016; Bromley et al., 2015; Hall et al., 2016; Kiviniemi, Klasko-Foster et al., 2018;
Mastrokostas et al., 2018). Fear presented in the form of fear of the findings from the
procedure as well as fear of the procedure itself (Bromley et al., 2015).
Colonoscopy is the most popular form of CRC screening, and includes multiple
steps like scheduling, bowel preparation, sedation, and the procedure itself; some of
which contain multiple levels of compliance (Powers et al., 2018). For example,
strategies such as enhanced written education, media campaigns, and videos improve
compliance the bowel preparation step of colonoscopies (Andrealli et al., 2018; Cole et
al., 2019; Essink-Bot et al., 2016). However, they were demonstrated as less effective to
improve patient health literacy and compliance for completing the colonoscopy procedure
(Clark et al., 2017; Enard et al., 2015; Mishra et al., 2018).
Medicare recognizes four methods of colonoscopy screening to demonstrate
compliance with the ACO #19 measure (Prince et al., 2017). These include colonoscopy,
DNA, stool testing, and fecal occult blood test. Studies suggest CRC compliance varies
with the type of test offered, Thus, could impact the CRC screening recommendations

32
that providers make to their patients (Alsayid et al., 2019; Basch et al., 2016; Bian et al.,
2016; Brenner & Chen, 2017; Bromley et al., 2015; Chambers et al., 2016).
My study fills a gap in research by focusing on provider practice characteristics
and the abilities of providers to influence the behavior of ACO patients to achieve
compliance with CRC screening recommendations.
Research Questions and Design
The nature of the manuscript is a cross-sectional quantitative study for the
following research question:
Based on the performance measures of the MSSP, what is the relationship
between practice size and compliance with MSSP performance measure ACO #19?
H0: There are no statistically significant differences in compliance with MSSP
performance measure ACO #19 based on practice size.
Ha: There are statistically significant differences in compliance with MSSP
performance measure ACO #19 based on practice size.
Cross-sectional quantitative studies are descriptive research to describe
community characteristics at a single point in time. I analyzed data from the MSSP PUF
from 2019. I assessed the relationship of dependent variable ACO performance for
measure ACO #19 and the independent variable practice size. My research design
required a way of to measure patient behavior. CMS ACO #19 is a cumulative measure
based on the number of people that participated in CRC screening. Therefore, I assumed
that CMS data are a valid measure of patient behavior.
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Methods
Operational Definitions
ACO #19: Percentage of adults between 50–75 years of age who had appropriate
screening for CRC for ACO quality reporting (CMS, 2017).
Alternative payment delivery models (APMs): Several experimental
advance/APMs have been created with varying success to introduce new patient
engagement initiatives to combat the United States skyrocketing healthcare costs (Noble
et al., 2014).
Attribution: The patients assigned to the health care provider for which they are
being measured (Noble et al., 2014).
Patient engagement: Studies show that improvements in patient engagement lead
to better health outcomes (Simmons et al., 2014).
Practice size: The number of patients and the number of primary care physicians
in an ACO.
Bias and Limitations
I analyzed archived data from the CMS. Therefore, the quality of this quantitative
data source was beyond my control as the researcher and contingent on the data
collection process for MSSP reporting (Burkholder et al., 2016). CMS (2017) allows
providers to review and dispute published performance data, followed by a final CMS
ruling. I used the final report issued by CMS, which included corrections to improve data
quality. I could not control confounding variables that may influence provider–patient
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attribution (Noble et al., 2014). These included patient comorbidities that can affect
patients abilities to comply with healthcare treatment plans (DeJean et al., 2013).
Scope and Delimitations
The MSSP ACO PUF details physician performance against 32 measures across
four domains (CMS, n.d.). The results are the official CMS findings and used to pay
provider incentives (Noble et al., 2014). Therefore, these measures are valid
representations of physician performance. The scope of my study was to evaluate
physicians’ performance against the CMS measurement for colon cancer screening ACO
#19.
I limited my target population to the subset of organizations that had previous
experience with MSSP ACOs and those who reported data for the 2019 MSSP reporting
year. Excluding first-year MSSP participants improved credibility by ensuring that
providers in the sample had a baseline measurement that reflected their performance
better (Noble et al., 2016). Disparities in provider–patient interactions may be influenced
by the factors race and patient insurance coverage (Foo et al., 2017). Therefore, a third
delimitation limited the participant sample to those with a patient base with at least 10%
non-White and accept both Medicaid and Medicare patients (CMS, 2017). Succesful
attainment of ACO #19 was determined by a score of at least 30% (CMS, 2017). I
differentiated well-performing providers from poor performing using this recognized
benchmark as a fourth delimitation (CMS, 2017).
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Design
Positivism guided the cross-sectional quantitative study to answer the question,
“How effective are providers at influencing patient behavior based on the performance
measure ACO #19 of the Medicaid Shared Savings Plan?” Archival data analysis from
the CMS 2019 MSSP PUF supported the positivist approach to my research question. I
used the quality performance data for healthcare providers reported in the PUF to
determine their effectiveness at influencing patient behavior as it correlated to their
practice size.
Instrumentation
Archival data from the MSSP PUF for 2019 was used for the data collection
process. The MSSP ACO PUF was derived from a combination of provider claims and
survey data. The PUF files are available for performance years 2013-2019. The PUF file
included hundreds of variables, descriptions and performance measure outcomes. These
included measures for six behavior related preventative measures. Performance measures
were captured as a percent of the total population where a higher score means higher
performance for that measure.
Provider incentives for MSSP ACOs were based on quantitative analysis of their
performance against established benchmarks (Noble et al., 2014). As such the current
reporting for the effectiveness of APMs is dichotomous as the providers did or did not
meet their measurement objectives (CMS, n.d.). This clear determination of provider
success supports a quantitative ontology of positivism in which there is one true reality
(Burkholder et al., 2016). Furthermore, quantitative analysis of provider performance
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using MSSP public use data is an accepted practice among the healthcare community
(Noble et al., 2016).
Participants
I limited the evaluation of provider performance to organizations in the United
States who had previous ACO experience prior to 2019 and who reported data for the
2019 MSSP reporting year. Previous studies showed that providers treated patients
differently according to sociodemographic characteristics (Foo et al., 2017; Manteuffel et
al., 2014). Therefore, I restricted participants to ACOs with a patient base of at least 10%
non-White and who accepted both Medicaid and Medicare patients. Furthermore, CMS
set a minimum standard of 30% achievement to comply with MSSP guidelines.
Therefore, participant selection was based on provider performance compared to the
30% benchmark.
Data Sources
Archival data was reviewed from the MSSP PUF for 2019. I used data for new
and returning ACO participants from the 2019 MSSP PUF. I described the extent that
ACOs were successful with measure ACO #19. I uploaded the entire MSSP PUF
database into SPSS v25 for review, analysis and statistical testing.

Quantitative Collection and Analysis
I assessed how effective ACOs were at changing patient behavior. I described the
extent that ACOs were successful at achieving colon cancer screening for measure ACO
#19. I uploaded the entire 2019 MSSP PUF database into SPSS v25 for review, analysis
and statistical testing. I retained the native MSSP PUF document, which was uploaded
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multiple times with all statistical tests replicated to ensure integrity and reliability. I used
Pearson Correlation and linear regression to determine if there was a significant
relationship between ACO practice size and performance. The level of significance was
set to 0.05.
Results
Research question: Based on the performance measures of the MSSP, what is the
relationship between practice size and compliance with MSSP performance measure
ACO #19?
H0: There are no statistically significant differences in the compliance of MSSP
performance measure ACO #19 based on practice size.
Ha: There are statistically significant differences in the compliance of MSSP
performance measure ACO #19 based on practice size.
Execution
I assessed archival data from the MSSP PUF (CMS, n.d.) for 2019 for 470 ACOs.
I calculated an additional variable to reflect the percentage of the total population by race,
age, gender, and Medicaid status in Microsoft Excel. The modified file was then entered
into SPSS version 25 to organize, code, and screen data. Data for ACO #19 score and
practice size were recoded to ordinal categorical data. Values were calculated including
frequency counts and percentages with SPSS. Descriptive data analysis was performed
for frequencies for all ACOs.
The final sample size was narrowed to 140 ACOs based on the inclusion and
exclusion criteria for the study. These included previous experience in the MSSP
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program and an ACO #19 score of 30 or more, an attribution that was at least 10% nonWhite. I performed statistical assumption tests for normal distribution, homoscedasticity,
and linearity between dependent and independent variables before research question
analysis. Table 1 summarizes the dependent, independent variables, and statistical
analyses used to evaluate the research question.
Table 1
Variables and Statistical Tests Used to Evaluate Research Questions
Research Question
What is the relationship
between practice size and
compliance with MSSP
performance measure ACO
#19?
What is the relationship
between practice size and
compliance with MSSP
performance measure ACO
#19?

Dependent
Variable

Independent Variable

Analysis

ACO #19 Score

Practice Size-Providers

Pearson Correlation
Linear Regression

ACO #19 Score

Practice Size-Attribution

Pearson Correlation
Linear Regression

Note. ACO = accountable care organization
Descriptive Statistics for all ACOs
Descriptive analysis for all (n = 470) ACOs and the target sample (n = 140) were
conducted for ACO #19 performance. Frequencies were reviewed for practice size and
characteristics of ACO attributions for age, race, gender, and insurance. Table 2 shows
the ACO #19 performance with most organizations achieving between 50 and 90%.
Performance for the target population aligned with the larger base with most
organizations (n = 85) achieving between 70–89% followed by those between 50–69% (n
= 47).
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Table 2
ACO #19 Performance Range and Frequency
ACO #19 Score
0-29
30-49
50-69
70-89
90 to 100
Total

All ACOs
Frequency Percent
4
0.9
13
2.8
157
33.4
287
61.1
9
1.9
470
100.0

Target ACOs
Frequency Percent
4
47
85
4
140

2.9
33.6
60.7
2.9
100.0

Note. ACO = accountable care organization
Practice size as measured by primary care physicians ranged from 20 to 2,299.
Table 3 shows that most ACOs had less than 200 primary care providers with the
majority falling between 50–99 at roughly 22%.
Table 3
Range and Frequency of Primary Care Providers in ACOs
Primary Care Providers
0-49
50-99
100-149
150-199
200-249
250-299
300-349
350-399
400-499
500-599
600 or more
Total

All ACOs
Frequency Percent
72
15.3
101
21.5
74
15.7
41
8.7
30
6.4
25
5.3
15
3.2
16
3.4
30
6.4
16
3.4
50
10.6
470
100.0

Target ACOs
Frequency Percent
15
10.7
32
22.9
18
12.9
11
7.9
9
6.4
9
6.4
5
3.6
6
4.3
8
5.7
7
5.0
20
14.3
140
100.0

Note. ACO = accountable care organization

Table 4 shows the practice size characteristics based on patient attribution for all
ACOs. ACOs that did not report a score for ACO #19 (n = 4) were removed. Of the
remaining (n = 466) there was a total of 9,918,470 patients enrolled in the ACOs of
which 4,275,182 (43%) were male and 5,643,285 (57%) female. Eighty-six percent of the
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population was white and 14% non-White. Ages ranged from 0-64 (14%), 65-74 (46%),
75-84 (28%) and 85 or older (12%). Beneficiaries with Medicaid totaled 606,989. The
patient attribution for all ACOs ranged from 2,193 to 239,924 patients.
Table 4
Range and Percentage of Attributions Across All ACOs
Total Patients

Female
Male
Medicaid Patients
Non-Medicaid Patients
Total Age 0_64
Total Age 65_74
Total Age 75_84
Total Age 85Plus
White
Non-White

Minimum
2,193
1,240
953
67
1,346
262
817
619
186
479
97

Maximum
239,924
133,423
106,501
17,981
181,135
41,238
109,019
64,190
25,477
219,069
24,215

Sum
9,918,470
5,643,285
4,275,182
606,989
7,917,736
1,369,626
4,607,276
2,799,157
1,142,411
8,519,870
1,398,600

Percent
57%
43%
6%
80%
14%
46%
28%
12%
86%
14%

The attribution of most ACOs in the target population was under 40,000 patients.
Table five shows that over half of the ACOs carried an attribution of between 10,000 and
39,999 followed by a range of 2,193 to 9,999 (27%).
Table 5
Range and Percentage of Attribution
Attribution Range
0-9,999
10,000-39,999
40,000-79,999
80,000 or more
Total

Frequency
38
77
19
6
140

Percent
27.1
55.0
13.6
4.3
100.0

Tests of Assumptions
I conducted assumption tests of the dependent variable ACO #19. The data were
normally distributed and follow a normal distribution curve. The skewness and kurtosis
tests for normal distribution should fall between the rage of ± 2 and ±7 respectfully. The
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ACO #19 score data for skewness was -.287 and kurtosis was -.692. The KolmogorovSmirnov test for normality was insignificant at p>.05. Figure one shows the normal Q-Q
plot of the data.
Figure 1
Normal Q-Q Plot for ACO #19 Performance

Inferential Statistics Manuscript 1
Previous studies define practice size as the total number of patients or the total
number of primary care physicians. I found practice size as defined by the total number
of primary care physicians in the ACO did not significantly influence ACO #19
performance. However, the results showed that practice size as defined by the total
number of patients had a statistically significant influence on ACO #19 performance.
Thus, the null hypothesis that practice size does not have a significant influence on ACO
#19 performance was rejected. I used bivariate correlation to determine relationship
between the dependent variable ACO #19 Performance and independent variables for
practice size. There was not a significant correlation between ACO #19 performance and
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the number of primary care providers. However, there was a statistically significant
Pearson Correlation of .214 between ACO #19 and the number of patients with p = .011.
Figure two shows that as ACO #19 performance increases with the total number of
patients.
Figure 2
ACO Practice Size Attribution

Note. ACO = accountable care organization
Furthermore, analysis showed the number of non-White patients was not
significant but the percentage of the total population size that was non-White had a
negative correlation of -.416 and p<.001. See Table 6.
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Table 6
Correlation Between ACO #19 Performance and Practice Size

ACO #19
Performance

Pearson
Correlation
P value
N

ACO #19
Performance
1

Total
Patients
.214*

Primary Care
Physicians
0.087

Total
NonWhite
0.014

Non-White
Percentage
-.416**

140

0.011
140

0.309
140

0.871
140

0.000
140

Note. ACO = accountable care organization. *. Correlation is significant at the 0.05 level
(2-tailed). **. Correlation is significant at the 0.01 level (2-tailed).
Linear Regression
I used linear regression to further analyze the correlations between ACO #19
Performance and the independent variables of total patients and percent of population that
was non-White. The influence of total patients on performance was statistically
significant (F(1,138) = 6,596, p<.05).The total number of patients attributed to the
variance in positive correlation by 4.6% with an R2 value of .046 and adjusted R2 of .039.
ACO #19 performance increased as population size increased with a coefficient of B =
8.9.
The relationship between the percent of non-White patients of the total practice
size and ACO #19 performance was statistically significant (F(1,138) = 28.8, p<.05).The
percentage of non-White patients of the total population based attributed to the variance
in negative correlation by 17.3% with an R2 of .173 and an adjusted R2 of .167. ACO #19
performance decreased as the Non-White population increased with a coefficient of B = .298.
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Discussion
Interpretation
My research correlates with previous research around physician influence on
paitent behavior and patient compliance with physicina recommendations. For example,
Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did not
meet the U.S. Preventative Services Task Force recommendations for CRC screening
before the advent of Medicare ACOs. My findings showed that only four out of 470
ACOs did not meet the minimum performance score of 30 for ACO #19; however, 36%
of the 140 target ACOs scored under 70%.
Other studies showed that differences in the structures of provider practices
influenced their capacities to influence patient behavior (Casalino & Chenven, 2017;
Casalino et al., 2013; Kim et al., 2017; Pineault et al., 2016). ACOs are comprised of a
variety of specialists and facility partnerships contractually committed to supporting care
delivery for ACO beneficiaries. Studies showed that providers believed collaborative
partnerships might mediate resource constraints tied to their practice size (Kim et al.,
2017). As such, my study supported their summation and found no statistical significance
between the number of primary care providers in an ACO and their performance with
ACO #19. Thus, collaboration may have mediated variances related to practice size
constraints. Previous research also suggested that ACO performance flattened after the
initial ACO period. This could also account for some similarities in ACO performance
across the target population.
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My findings showed that the total number of patients in an ACO had a statistically
significant correlation to ACO #19 performance. This aligned with previous research that
practice size as defined by the number of patients predicted success with CMS quality
measurements (Greene et al., 2015). Furthermore, previous research showed disparities
across socioeconomic and racial/ethnic boundaries (Bromley et al., 2015). I found a
statistically significant correlation that more non-White patients in an ACO resulted in
lower performance scores. This aligned with previous studies where non-White patients
were less likely to complete CRC screening (Basch et al., 2016; Bromley et al., 2015;
Hall et al., 2016; Kiviniemi et al., 2018; Klabunde et al., 2015; Mastrokostas et al., 2018).
Thus, the results supported a growing body of evidence that documented disproportionate
racial and socioeconomic disparities for patient compliance (Ashktorab et al., 2017;
Bromley et al., 2015; Burnett-Hartman et al., 2016; Chablani et al., 2017).
Interpretation in the Context of the Socioecological Model
My study was guided by the SEM. Under the SEM, provider performance is
affected by factors that influence both their decision making and their effectiveness to
change patient behavior (Rabarison et al., 2013). My findings showed that participation
in an ACO and practice size may influence provider effectiveness to change patient
behavior. Furthermore, the findings demonstrate factors related to the characteristics of
their patients influences their effectiveness. Society/policy factors tied to creating ACOs
and their CMS quality measurements (i.e., success defined by a score of at least 30 for
ACO #19) are also influential.
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Limitations
There are limitations to my study. First, I excluded new ACOs from the full
analysis. Thus, the range of performance of the sample population (n = 140) may not
reflect the distribution of the entire ACO base (n = 470). Nor may it reflect provider
patient relationships for providers and patients that do not participate in ACOs. Caution
should be used when generalizing these results for other applications. Second, the MSSP
PUF file data are restricted to the variables within the data set.
The file does not provide CRC screening results at the individual level for patients
or providers. Thus, my findings are limited to generalizations about ACOs based on total
number of providers, total number of patients, and percentages of patients with certain
characteristics. As a result, I am unable to articulate differences in ACO #19 compliance
at the individual patient and rely instead solely on the ACO #19 performance score. I am
also unable to articulate difference at the individual provider level. Lastly, the MSSP
PUF has a one-year delay in reporting. The results were provided before the significant
change in care delivery due to the COVID-19 pandemic and may influence the
generalizability for future applications.
Implications
ACOs are partnerships among care providers including public health
organizations. My study can improve public health and healthcare professionals’ ability
to influence the behaviors and health outcomes of the community members they serve.
This is a vital component of current efforts to screen for COVID-19, promote adoption of
behaviors to slow the spread of COVID-19 and adoption of COVID-19 vaccinations. The
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CMS (2012) stated that more than 70% of patients over the age of 65 have two or more
chronic conditions. The management of patients with multiple chronic diseases is more
difficult than in those suffering from a single condition (Wagner et al., 2013). Wang et
al., observed (2020) that elderly COVID-19 patients were among the most severe to
critical cases with a high rate of fatality. Thus, the results of my study apply to current
efforts for high risk elderly patients, their providers, and communities
Cancer screening rates have declined due to the COVID-19 pandemic (Carethers
et al., 2020). The COVID-19 pandemic disproportionality affected minority communities
and further resulted in even lower screening rates for minority populations (Carethers et
al.). As such, Carethers et al., posit that extended delays in cancer screening is expected
to lead to increase cancer for all populations. This is expected to be elevated in minorities
and lower socio-economic people. My study offers insight as to which populations may
be at greater risk based on their previous experience with CRC screening before the
pandemic.
My study showed that ACOs with more patients were more compliant with CRC
screening recommendations. Yet, it showed that ACOs with more Black patients were
less compliant than those with less. It also revealed that the number of providers in an
ACO did not influence compliance with CRC screening recommendations. My findings
supported previous research that showed disparities among non-White patient
populations. My research helps to decrease the prevalence of CRC and by doing so
reduce the economic and quality of life burden for individuals and communities affected
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by the disease. Moreover, my study helps to reduce disparities for CRC screening and
incidence of CRC among vulnerable populations.
My study promotes positive social change by providing a foundation for
population health initiatives beyond CRC related illness Thus, improving the wellbeing
of communities and increase public health emergency preparedness. It provides
meaningful data to the public health and health care provider partnerships engaged in
transforming healthcare from a transactional delivery system to an evidence-based system
of value (Berenson et al., 2016). It will influence policies that support health and wellness
initiatives in communities of color. Furthermore, it will influence policies that govern the
minimum number of patients in ACOs that might influence CRC screening rates for
elderly patients. Furthermore, it can influence policy related to provider patient ratios and
patients aged 65 year and older ...
Lastly, my study can offer guidance to public health and healthcare provider
leaders on ways to train professionals better, reduce frustration, improve success and
achieve higher levels of satisfaction in their work both in routine interventions and public
health emergencies.
Recommendations
Several recommendations resulted for additional research from my study.
Additional analysis should be conducted for further assessment of ACO #19 performance
related patient base characteristics, age, race, sex, and socio-economic status. Second,
CRC screening is the most complex behavior measured for ACOs. These include a
variety of tests some of which have multiple compliance steps like those with

49
colonoscopy screening. This contrasts with dichotomous behaviors such as receiving a
flu-vaccinations. I recommend future studies to compare complex behavior such as CRC
with dichotomous decision like receiving an influenza vaccination.
The study should also be replicated for all 470 ACO participants. This may
provide insight on differences and similarities to new and experienced ACOs. The study
should also include provider feedback using tool like the primary care provider
Behavioral Health Intervention Survey. The original tool was designed to assess provider
perceptions of factors that influence their intention to use interventions when treating
children with mental health problems and can be modified for adults (Arora et al., 2016).
Lastly the study should be replicated and expanded as a mixed methods
explanatory sequential study. Mixed methods integrates open-ended qualitative data with
closed-ended quantitative data from inquiry (Creswell, 2009). Mixed methods strategy is
purpose-driven research to provide a more in-depth insight into how health professionals
influence participant behavior (Creswell, 2009). Mixed methods can develop a more
comprehensive understanding of changes needed for population engagement as well as
understanding the process and outcomes of current patient engagement strategies
(Creswell, 2009).
Conclusion
Health care delivery and public health have overlapping efforts like health
screening activities for better health outcomes and to lower the burden of disease
(Cunningham et al., 2020). Partnerships between community-based organizations, health
care delivery and public health organizations improve public health outcomes. Studies
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showed patient behavior was the key to improve quality and health outcomes (Mogre et
al., 2019).
The MSSP ACO is partnership based advanced payment model designed to curb
cost and improve patient outcomes for colon cancer among other disease measures. CRC
is a leading cause of death in the United States, (Loyd, 2016) and more research is needed
to determine the impact of MSSP ACO providers on CRC screening.
Previous research found disparities in health behavior recommendation
compliance among people based on patient base characteristics and the size of their
providers’ practices (Kiviniemi et al., 2018; Manteuffel et al., 2014). My study sought to
determine the relationship between practice size and compliance with MSSP performance
measure for colonoscopy screening ACO #19. I explored practice size as the number of
primary care providers and the total number of patients. My findings correlate with
previous research around physician influence on paitent behavior and patient compliance
with physician recommendations. My results showed that the number of primary care
physicians in an ACO did not influence their ACO #19 score. Thus, their participation
and collaboratoin in an ACO may have mediated some of the contraints found in other
studies based on practice that could influence ACO performance. My study found that
ACOs with more patients performed better. This aligned with previous research where
practice size as defined by the number of patients predicted success with CMS quality
measurements. However, performance declined as the number and percentage of minority
patients increased. This aligned with previous research which showed disparities exist
across socioeconomic and racial/ethnic boundaries.
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My study addressed the gap in research by focusing on participant behavior of
ACOs with different size patient populations and the number of primary care providers in
their organizations. It contributes to positive social change by providing meaningful data
to public health partnerships and policy makers that determine the size and structure of
ACOs. Therefore, the application of my findings can improve the ability of public health
and healthcare providers to predict their influence the behaviors and health outcomes of
the community members they serve.
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Provider Influence on Patient Behavior Related the Population’s Race, Age, and
Gender

Harry Petaway

Walden University

Objective: This study assessed the preventative quality performance measure (ACO #19)
for colon cancer screening under Medicare Shared Savings Plan ACO guidelines. I
quantified the overall performance of ACO #19 based on the population’s demographics
of race, age and gender.

Methods: A cross-sectional quantitative study was conducted for organizations who
participate as a Medicare Shared Savings Plan Accountable Care Organization. The
research included secondary data analysis of the 2019 Medicare Shared Savings Plan
PUF on quality performance.
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Abstract
Public health efforts include initiatives like vaccination and screening to reduce the
burden of disease. This study used the socioecological model and a cross-sectional
quantitative design to assess data from the Medicare Shared Savings Plan public use file
2019 to examine patient behavior as the primary driver to improve healthcare quality and
reduce costs. This study focused on colorectal cancer (CRC) screening behaviors of
accountable care organization (ACO) patients based on the age, gender, and race
differences of the patient population. ACOs with more non-White patients were less
successful with CRC screening, and performance was highest when more patients were
between 65-85 years of age when compared to patients under 65 or over 85 years old.
The implications for positive social change in this study include data for policy makers,
health, and public health care professionals to reduce disparities for CRC screening and
incidence of CRC among vulnerable populations. Therefore, the application of the
findings can improve the ability of public health and healthcare providers to predict their
influence on behavior and health outcomes of the community members they serve.
Furthermore, the study supports policies and processes around cultural awareness and
cultural competencies to contribute to better healthcare delivery.
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Introduction
Healthcare costs in the United States are rising at an unsustainable rate (Noble et
al., 2014), and significant disparities in health outcomes exist across the U.S. population
attributed mainly to social determinants of health (Foo et al., 2017). As a result, public,
community and clinical health professionals in several communities formed partnerships
under new public healthcare delivery models designed to improve public health by
addressing social determinants of health and changing individual behavior (Bachrach et
al., 2016; Noble et al., 2014). For example, the Institute of Healthcare Improvement’s
Quadruple Aim outlined a framework to improve health outcomes, lower healthcare
costs, improve patient experience, and improve clinician satisfaction (Wagner et al.,
2018). In fact, experimental alternative payment delivery models (APMs) were created
with varying success to achieve components of the Quadruple Aim (Noble et al., 2014).
Studies have shown that improvements in population engagement led to better health
outcomes (Simmons et al., 2014). Population engagement by providers is essential to
guide community members toward behaviors that lead to healthier outcomes, which may
reduce the overall cost of care (Grand et al., 2014). However, there was little evidence of
which strategies were most successful at influencing their patients’ behavior.
Problem
Physicians have suggested that patient behavior is the key to improve health
quality and outcomes, yet it is difficult to influence individual behavior (Hibbard et al.,
2015). Moreover, researchers have found disparities in patient compliance with health
behavior recommendations (Kiviniemi et al., 2018; Manteuffel et al., 2014), which are
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linked to patient characteristics and provider variables like the size of provider practices
(Kiviniemi et al., 2018; Manteuffel et al., 2014) Data on the patient experience are
captured in performance reporting through the Centers for Medicare and Medicaid
Services (CMS, n.d.), and patient perspectives toward patient engagement were well
documented in the literature (Rowland et al., 2017). However, provider experiences,
perceptions, success, and strategies to engage community members attributed to their
APMs has not been represented in detail in previous research (Andrealli et al., 2018;
Bekmuratova et al., 2019; Berenson et al., 2016; Chen et al., 2016). Thus, there is an
inability to replicate the best practices for population engagement, that improve
participant experiences, job satisfaction, health outcomes, and lower costs. To address
this gap, I explored the preventative quality performance measure for colon cancer
screening ACO #19 for the Medicare Shared Savings Plan (MSSP) guidelines based on
race, age, and gender of the patient population.
Significance of the Study
APMs introduced patient engagement initiatives to lower the U.S. healthcare costs
with different levels of success (Noble et al., 2014). Significant disparities in health
outcomes exist across the U.S. population attributed mainly to social determinants of
health (Foo et al., 2017). Extensive quantitative data on APM quality are captured by
CMS performance reports (CMS, n.d.). The literature, however, lacks evidence as to why
physicians were successful at influencing patient behavior. One study of an emerging
United Kingdom healthcare model showed that the number of focus groups was increased
when providers received payments to develop community-based participatory patient
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focus groups to improve provider care delivery, but the quality of care was not improved
(Smiddy et al., 2015). In the current study, exploring provider experiences with managing
patient populations of different ages, genders, and ethnicities might explain to what
degree they effect patient behavior compared to the measures that determine their
payments.

Relevant Contribution to the Body of Knowledge
The purpose of my study was to assess the relationship between an ACO
population's demographics race, age, and provider effectiveness at influencing patient
behavior as measured by the compliance of MSSP performance measure ACO #19. This
manuscript addresses a gap in research by focusing on provider practice characteristics
based on age, gender, and race. This manuscript is a cross-sectional quantitative study to
explore the preventative quality performance for colon cancer screening under MSSP
ACO guidelines based on the described social determinants of health distribution of the
patient population. My cross-sectional study provides a more comprehensive assessment
of physician influence on patient behavior than studies like those from CMS.
Framework
The socioecological model (SEM) guided my cross-sectional quantitative study. I
assessed data from the MSSP public use file (PUF). Under the SEM, provider
performance is affected by factors that influence both their decision making and their
effectiveness to change patient behavior (Rabarison et al., 2013). SEM posits five
categorical levels which affect behavior change: the individual, interpersonal,
organizational, community/environment, and society/policy levels (Lampard et al., 2013).
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While the factors of the SEM are hierarchical, they are also integrated, and a change in
one area could impact others (Coreil, 2009).
The positivist ontology also guides my study. Positivism implies that there is a
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment
through a PUF. Thus, these results reflect a single truth of their performance. My study
assessed how patients’ race, age, and gender predicts providers’ ACO #19 measure
attainment. These findings are the source of truth under the positivist ontology for my
study
My research is influenced by multiple contexts. The personal contexts for my
study include my knowledge and experience with advance payment models and patient
engagement. The social contexts include CMS guidelines, the fluidity of US healthcare
policy, political climate, geographic locations, and local healthcare delivery priorities.
Lastly, interpersonal contexts include Walden University dissertation committee
representatives.
The definition of “provider success” is precise and supports a quantitative
ontology of positivism where there is one true reality (Burkholder et al., 2016).
Positivism guided my cross-sectional quantitative study to answer the question “How
effective were providers at influencing patient behavior based on the performance
measure ACO #19 of the Medicaid Shared Savings Plan?” I analyzed archival data from
the CMS to support the positivist approach to my research question (Burkholder et al.,
2016).
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Background
Colorectal cancer (CRC) is a leading cause of death in the United States (Lloyd,
2016). The Centers for Disease Control and Prevention estimated over 40,000 deaths
attributed to colon cancer in 2016 (Bachman et al., 2018). The risk of CRC mortality can
be reduced with early detection (Lloyd, 2016). Focused efforts to increase CRC screening
led to a reduction of CRC related deaths in the last decade; yet, several disparities
continue to exist across socioeconomic and racial/ethnic boundaries (Bromley et al.,
2015). Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did
not meet the U.S. Preventative Services Task Force recommendations for CRC screening
before the advent of Medicare ACOs.
APMs were created to fight rising health care costs in the United States (Noble et
al., 2014). ACOs are one of the advanced payment models designed to shift the focus of
healthcare services from a traditional fee for service structure to a value-based care
model. CRC screening is a key focus and measurement of ACOs. The propensity for
provider recommendations for appropriate screening based on the Preventative Services
Task Force recommendations for CRC screening was very low before the advent of
Medicare ACOs (Klabunde et al., 2015). This problem was further exacerbated by racial
disparities where African American and Hispanic individuals were less likely to complete
screening and had an increased prevalence of adverse health outcomes as a result
(Klabunde et al., 2015).
A growing body of evidence among other research further documented
disproportionate racial and socioeconomic disparities and highlighted the diverse cultural
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needs to motivate patients toward compliance (Ashktorab et al., 2017; Bromley et al.,
2015; Burnett-Hartman et al., 2016; Chablani et al., 2017). Many studies offered
anecdotal patient interventions that improved patient compliance (Nathan et al., 2016;
Singal et al., 2017; Slyne et al., 2017). Studies that focused on patient experience
reinforced culturally competent approaches based on varying patient demographics
(Alsayid et al., 2019; Brittain & Murphy, 2015; Chen et al., 2016).
Fear was demonstrated to be a major influence for compliance by all patients, but
particularly among blacks and Hispanics (Basch et al., 2016; Bromley et al., 2015; Hall et
al., 2016; Kiviniemi et al., 2018; Mastrokostas et al., 2018). Fear emerged as fear of both
fear of undergoing the procedure and fear of the procedure’s findings (Bromley et al.,
2015). Ineffective communication and perceived provider uncertainty also affected the
patient decision-making process (Beverly et al., 2016). This was confounded by patients'
expectations of the provider (Alspach, 2018; Mast & Kadji, 2018). For example,
uncertainty was seen as a form of truthfulness for female providers, whereas the trait
generated mistrust for male providers (Mast & Kadji, 2018). Moreover, trust was
demonstrated to be a contributing factor behind non-compliance of CRC screening for
many Hispanic patients (Hong et al., 2018). Studies also showed providers adherence to
evidence-based treatment guidelines differed when treating men vs women (Manteuffel et
al., 2014). Still more evidence reported unconscious bias by providers when treating
patients of different race, age, and socioeconomic groups. (Williams et al., 2015).
Medicare recognizes four methods of colonoscopy screening to demonstrate
compliance with the ACO #19 measure (Prince et al., 2017). These include colonoscopy,
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DNA, stool testing, and fecal occult blood test. Studies suggest CRC compliance varies
with the type of test offered, Thus, could impact the CRC screening recommendations
that providers make to their patients (Alsayid et al., 2019; Basch et al., 2016; Bian et al.,
2016; Brenner & Chen, 2017; Bromley et al., 2015; Chambers et al., 2016).
Colonoscopy is the most popular forms of CRC screening, and includes multiple
steps like scheduling, bowel preparation, sedation and the procedure itself; some of which
contain multiple levels of compliance (Powers & Keohane, 2018). Some of steps to
obtain a colonoscopy contain multiple levels of compliance and complexity themselves
(Powers et al., 2018). For example, strategies such as enhanced written education, media
campaigns, and videos improved compliance with the bowel preparation step for
colonoscopies (Andrealli et al., 2018; Cole et al., 2019; Essink-Bot et al., 2016).
However, they were demonstrated as less effective to improve patient health literacy and
compliance to complete a colonoscopy procedure (Clark et al., 2017; Enard et al., 2015;
Mishra et al., 2018).
Success varied among the initial United States APMs (Noble et al., 2014).
Hibbard et al. (2015) documented that compensation from APMs in other countries
influenced physician opinions on the importance of patient behavior. They further
provided evidence that patient behavior was the primary driver of improving quality
(Hibbard et al., 2015). Other studies showed that improvements in patient engagement
lead to better health outcomes (Grand et al., 2014; Simmons et al., 2014).
Physicians in the United States agreed that patient behavior was the key
determinant to improve quality and outcomes, yet, many found frustration when they
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tried to influence individual behavior (Hibbard et al., 2015). While many providers
perceived their role within the community and in population health as “medicine-based”;
a growing emphasis on preventative care and the complex characteristics of their
attributed patient base fostered better collaboration between healthcare providers and
traditional public health organizations (Ingram et al., 2015). This was particularly true for
mutual objectives such as cancer prevention (Basch et al., 2016).
Nyweide et al. (2015) showed the initial performance under the Medicare ACO
model reduced healthcare expenditures for the attributed population base when compared
to traditional Medicare fee-for-service beneficiaries. The CMS measures ACO providers
across four domains, which include care coordination, patient safety, patient experience,
and preventative health (Modi et al., 2018). Providers are rewarded for lower cost of
patient care and achieving quality metrics outlined in their ACO contracts.
Studies documented provider perceptions of barriers and provider characteristics
that influenced their decision making and success (Mastrokostas et al., 2018; Wang et al.,
2018). These included the basic ability to verify patient’s correct CRC status and the
clinician’s ability to confer with specialists (Mastrokostas et al., 2018) For example, a
provider recommendation was a primary influence on whether patients of all
demographic groups participated in CRC screenings (Bian et al., 2016; Bromley et al.,
2015). Some studies showed that health information technologies that shared patient
information or alerted providers to the patient’s CRC risk and screening status nudged
providers to provide CRC screening recommendations (Kim et al., 2017b; Mankaney et
al., 2019). Additionally, other studies reiterated the importance of Patient Behavior on
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quality performance and the need to implement systems to support patient engagement
activities to influence behavior (Mishra et al., 2018). These included the concepts of,
motivational interviewing, goal setting, and shared decision making (Mishra et al., 2018).
However, Mishra and colleagues (2018) reported that providers were aware of these
concepts but often lacked the depth of understanding and practice to implement them in a
meaningful way. Shapiro et al. (2018) further described provider experiences with tough
to manage patients in which providers described themselves as anxious, frustrated, and
uncertain with little preparation for how to handle difficult patients. My study addressed a
gap in research and focused on the patient attribution characteristics and provider
strategies that influence the behavior of APM patients to achieve compliance with CRC
screening recommendations.
Research Question and Design
The nature of the manuscript is a cross-sectional quantitative study for the
following research questions:
Based on the performance measures of the MSSP, what is the relationship
between the ACO population's demographics race, age, and how effective providers are
at influencing patient behavior as measured by the compliance of MSSP performance
measure ACO #19?
H0: There are no statistically significant differences in compliance of MSSP
performance measure ACO #19 based on the ACO population's demographics, race, age,
and gender.
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Ha: There are statistically significant differences in compliance of MSSP
performance measure ACO #19 based on the ACO population's demographics, race, age,
and gender.
Cross-sectional quantitative studies are descriptive research to describe
community characteristics at a single point in time. I analyzed data from the MSSP PUF
from 2019. I assessed the relationship of dependent variable ACO performance for
measure ACO #19 and the independent variables race, age and gender. My research
design required a way of to measure patient behavior. CMS ACO #19 is a cumulative
measure based on the number of people that participated in CRC screening. Therefore, I
assumed that CMS data is a valid measure of patient behavior.
Methods
Operational Definitions
ACO #19: Percentage of adults between 50–75 years of age who had appropriate
screening for CRC for ACO quality reporting (CMS, 2017).
Alternative payment delivery models (APMs): Several experimental
advance/APMs have been created with varying success to introduce new patient
engagement initiatives to combat the United States skyrocketing healthcare costs (Noble
et al., 2014).
Attribution: The patients assigned to the health care provider for which they are
being measured (Noble et al., 2014).
Patient engagement: Studies show that improvements in patient engagement lead
to better health outcomes (Simmons et al., 2014).
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Practice size: The number of patients and the number of primary care physicians
in an ACO.
Bias and Limitations
I analyzed archived data from the CMS. Therefore, the quality of this quantitative
data source was beyond my control as the researcher and contingent on the data
collection process for MSSP reporting (Burkholder et al., 2016). CMS (2017) allows
providers to review and dispute published performance data, followed by a final CMS
ruling. I used the final report issued by CMS, which included corrections to improve data
quality. But I could not control confounding variables that may influence provider–
patient attribution (Noble et al., 2014). These included patient comorbidities that can
affect patients abilities to comply with healthcare treatment plans (DeJean et al., 2013).
Scope and Delimitations
The MSSP ACO PUF details physician performance against 32 measures across
four domains (CMS, n.d.). The results are the official CMS findings and used to pay
provider incentives (Noble et al., 2014). Therefore, these measures are valid
representations of physician performance. The scope of my study was to evaluate
physicians’ performance against the CMS measurement for colon cancer screening ACO
#19.
I limited my target population to the subset of organizations that had previous
experience with MSSP ACOs and those who reported data for the 2019 MSSP reporting
year. Excluding first-year MSSP participants improved credibility by ensuring that
providers in the sample had a baseline measurement that reflected their performance
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better (Noble et al., 2016). Disparities in provider–patient interactions may be influenced
by the factors race and patient insurance coverage (Foo et al., 2017). Therefore, a third
delimitation limited the participatn sample to those with a patient base with at least 10%
non-White and accept both Medicaid and Medicare patients (CMS, 2017). Succesful
attainmnet of ACO #19 was detrmined by a score of at least 30% (CMS, 2017). I
differentiated well-performing providers from poor performing using this recognized
benchmark as a fourth delimitation (CMS, 2017).
Design
Positivism guided the cross-sectional quantitative study to answer the question,
“How effective are providers at influencing patient behavior based on the performance
measure ACO #19 of the Medicaid Shared Savings Plan?” Archival data analysis from
the CMS 2019 MSSP PUF supported the positivist approach to my research question. I
used the quality performance data for healthcare providers reported in the PUF to
determine their effectiveness at influencing patient behavior as it correlated to their
practice size.
Instrumentation
Archival data from the MSSP PUF for 2019 was used for the data collection
process. The MSSP ACO PUF was derived from a combination of provider claims and
survey data. The PUF files are available for performance years 2013-2019. The PUF file
included hundreds of variables, descriptions and performance measure outcomes. These
included measures for six behavior related preventative measures. Performance measures
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were captured as a percent of the total population where a higher score means higher
performance for that measure.
Provider incentives for MSSP ACOs were based on quantitative analysis of their
performance against established benchmarks (Noble et al., 2014). As such the current
reporting for the effectiveness of APMs is dichotomous as the providers did or did not
meet their measurement objectives (CMS, n.d.). This clear determination of provider
success supports a quantitative ontology of positivism in which there is one true reality
(Burkholder et al., 2016). Furthermore, quantitative analysis of provider performance
using MSSP public use data is an accepted practice among the healthcare community
(Noble et al., 2016).
Participants
I limited the evaluation of provider performance to organizations in the United
States who had previous ACO experience prior to 2019 and who reported data for the
2019 MSSP reporting year. Previous studies showed that providers treated patients
differently according to sociodemographic characteristics (Foo et al., 2017; Manteuffel et
al., 2014). Therefore, I restricted participants to ACOs with a patient base of at least 10%
non-White and who accepted both Medicaid and Medicare patients. Furthermore, CMS
set a minimum standard of 30% achievement to comply with MSSP guidelines.
Therefore, participant selection was based on provider performance compared to the
30% benchmark.
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Data Sources
Archival data was reviewed from the MSSP PUF for 2019. I used data for new
and returning ACO participants from the 2019 MSSP PUF. I described the extent that
ACOs were successful with measure ACO #19. I uploaded the entire MSSP PUF
database into SPSS v25 for review, analysis, and statistical testing.

Quantitative Collection and Analysis
I assessed how effective ACOs were at changing patient behavior. I described the
extent that ACOs were successful at achieving colon cancer screening for measure ACO
#19. I uploaded the entire 2019 MSSP PUF database into SPSS v25 for review, analysis
and statistical testing. I retained the native MSSP PUF document, which was uploaded
multiple times with all statistical tests replicated to ensure integrity and reliability. I used
Pearson Correlation and linear regression to determine if there was a significant
relationship between ACO practice size and performance. The level of significance was
set to 0.05.
Results
Research question: Based on the performance measures of the MSSP, what is the
relationship between the ACO population’s demographics race, age, and gender and
compliance with MSSP performance measure ACO #19?
H0: There are no statistically significant differences in compliance with MSSP
performance measure ACO #19 based on the ACO population's demographics, race, age,
and gender.
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Ha: There are statistically significant differences in compliance with MSSP
performance measure ACO #19 based on the ACO population’s demographics, race, age,
and gender.
Execution
Archival data from the MSSP PUF (CMS, n.d.) for 2019 were assessed for 470
ACOs. I calculated an additional variable to reflect the attribution percentages for race,
age, gender, and Medicaid status in Microsoft Excel. The modified file was then entered
into SPSS version 25 to organize, code, and screen data. Data for ACO #19 score and
number of primary care providers were recoded to ordinal categorical data. Values were
calculated including frequency counts and percentages with SPSS. Descriptive data
analysis was performed for frequencies for all ACOs.
The final sample size was narrowed to 140 ACOs based on the inclusion and
exclusion criteria for the study. These included previous experience in the MSSP
program and an ACO #19 score of 30 or more, an attribution that was at least 10% nonWhite. I performed statistical assumption tests for normal distribution, homoscedasticity,
and linearity between dependent and independent variables before research question
analysis. Table 7 summarizes the dependent, independent variables, and statistical
analyses used to evaluate the research questions.
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Table 7
Variables and Statistical Tests Used to Evaluate Research Questions
Research Question
What is the relationship
between practice size
and compliance with
MSSP performance
measure ACO #19?

Dependent Variable

Independent Variable
Attribution Characteristics: Age
Attribution Characteristics: Race
Attribution Characteristics: Gender

ACO #19 Score

Analysis
Pearson
Correlation
Linear
Regression

Note. ACO = accountable care organization
Descriptive Statistics for all ACOs
Descriptive analysis for all (n = 470) ACOs and the target sample (n = 140) were
conducted for ACO #19 performance. Frequencies were reviewed for practice size and
characteristics of ACO attributions for age, race, gender, and insurance. Table 8 shows
the ACO #19 performance with most organizations achieving between 50% and 90%.
Performance for the target population aligned with the larger base with most
organizations (n = 85) achieving between 70–89% followed by those between 50-69% (n
= 47).
Table 8
ACO #19 Performance Range and Frequency
ACO #19 Score
0-29
30-49
50-69
70-89
90 to 100
Total

All ACOs
Frequency Percent
4
0.9
13
2.8
157
33.4
287
61.1
9
1.9
470
100.0

Target ACOs
Frequency Percent

Note. ACO = accountable care organization

4
47
85
4
140

2.9
33.6
60.7
2.9
100.0

Practice size as measured by primary care physicians ranged from 20 to 2,299.
Table 9 shows that most ACOs had less than 200 primary care providers with the
majority falling between 50-99 at roughly 22%.
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Table 9
Range and Frequency of Primary Care Providers in ACOs
Primary Care Providers
0-49
50-99
100-149
150-199
200-249
250-299
300-349
350-399
400-499
500-599
600 or more

Total

All ACOs
Frequency
Percent
72
15.3
101
21.5
74
15.7
41
8.7
30
6.4
25
5.3
15
3.2
16
3.4
30
6.4
16
3.4
50
10.6
470
100.0

Note. ACO = accountable care organization

Target ACOs
Frequency
Percent
15
10.7
32
22.9
18
12.9
11
7.9
9
6.4
9
6.4
5
3.6
6
4.3
8
5.7
7
5.0
20
14.3
140
100.0

Table 10 shows the practice size characteristics based on patient attribution for all
ACOs. ACOs that did not report a score for ACO #19 (n = 4) were removed. Of the
remaining (n = 466) there was a total of 9,918,470 patients enrolled in the ACOs of which
4,275,182 (43%) were male and 5,643,285 (57%) female. Eighty-six percent of the
population was white and 14% non-White. Ages ranged from 0-64 (14%), 65-74 (46%),
75-84 (28%) and 85 or older (12%). Beneficiaries with Medicaid totaled 606,989. The
patient attribution for all ACOs ranged from 2,193 to 239,924 patients.
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Table 10
Range and Percentage of Attributions Across all ACOs
Total Patients

Female
Male
Medicaid Patients
Non-Medicaid Patients
Total Age 0_64
Total Age 65_74
Total Age 75_84
Total Age 85Plus
White
Non-White

Minimum
2,193
1,240
953
67
1,346
262
817
619
186
479
97

Maximum
239,924
133,423
106,501
17,981
181,135
41,238
109,019
64,190
25,477
219,069
24,215

Note. ACO = accountable care organization

Sum
9,918,470
5,643,285
4,275,182
606,989
7,917,736
1,369,626
4,607,276
2,799,157
1,142,411
8,519,870
1,398,600

Percent
57%
43%
6%
80%
14%
46%
28%
12%
86%
14%

The attribution of most ACOs in the target population was under 40,000 patients.
Table 11 shows that over half of the ACOs carried an attribution of between 10,000 and
39,999 followed by a range of 2,193 to 9,999 (27%).
Table 11
Range and Percentage of Attribution
Attribution Range
0-9,999
10,000-39,999
40,000-79,999
80,000 or more
Total

Frequency
38
77
19
6
140

Percent
27.1
55.0
13.6
4.3
100.0

Tests of Assumptions
I conducted assumption tests of the dependent variable ACO #19. The data were
normally distributed and follow a normal distribution curve. The skewness and kurtosis
tests for normal distribution should fall between the rage of ± 2 and ±7 respectfully. The
ACO #19 score data for skewness was -.287 and kurtosis was -.692. The KolmogorovSmirnov test for normality was insignificant at .058. Figure three shows the normal Q-Q
plot of the data.
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Figure 3
Normal Q-Q Plot for ACO #19 Performance

Note. ACO = accountable care organization
Inferential Statistics Manuscript 2
I found that age and race characteristics of patients in an ACO had a statistically
significant influence on ACO #19 performance. Thus, the null hypothesis that age and
race do not have a significant influence on ACO #19 performance was rejected. Gender
did not significantly influence ACO #19 performance. The null hypothesis that gender
does not influence ACO #19 performance was accepted. I used bivariate correlation to
determine the relationship between the dependent variable ACO #19 performance and
independent variables for age, gender and race.

Age
Table 12 shows the correlations between age and ACO #19 performance. The
total number of patients in an ACO that were between 0-64 years old was not a
significant influence on ACO #19 performance. The total number of patients between the
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age of 65-74 was statistically significant with a positive correlation of .228 and p = .007.
The total number of patients between the age of 75-84 also had a positive correlation of
.240 and p = .004. The total number of patients over the age of 85 had a positive
correlation of .211 and p = .012.
The percentage of patients between 0-64 had a negative correlation of -.472 which
was statistically significant at p<.001. The percent of patients between 65-74 had a
positive correlation of .341 with p<.001. The percent of patients between 75-84 had a
positive correlation of .448 with p<.001. The percent of patients 85 and over was not a
significant influence on ACO #19 performance.
Table 12
Correlation Between Attribution Age and Performance
ACO #19
Performance

Pearson
Correlation
P value
N
Pearson
Correlation
P value
N

Attribution
Total

Attribution
Percentage

Age
65_74
.228**

Age
75_84
.240**

Age
85Plus
.211*

Age 0_64
-.472**

0.007
140
Age
65_74
.341**

0.004
140
Age
75_84
.448**

0.012
140
Age
85Plus
0.087

0.000
140

0.000
140

0.000
140

0.307
140

Age 0_64
0.045
0.598
140

Gender
Both the total number of male and the total number of female patients showed a
positive correlation that was statistically significant. However, this measure correlates to
the total number of patients in an ACO which was found to be statistically significant in a
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previous study. Alternatively, the percentages of male and female patients did not show a
statistically significant correlation on ACO #19 performance.

Race
Table 13 shows the correlations between race and ACO #19 performance. The
results showed statistically significant correlations for ACO #19 performance and total
number of white patients in an ACO. The total of white patients in an ACO had a positive
correlation of .244 with p = .244. The total of patients in an ACO that were a race other
than, White, Black, Asian, Hispanic or Native American also had a positive correlation
with ACO #19 performance of .167 and p=0.049.
The percent of the total patients in an ACO that were white had a positive
correlation with ACO #19 performance of .416 and p=0.00. The percent of Black and
Hispanic patient in the ACO had negative correlations with ACO #19 performance. The
percent of black patients had a negative correlation of -.365 and p = .00. The percent of
Hispanic patients had a negative correlation of -.222 and p = .008.
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Table 13
Correlation Between Attribution Race and CRC Screening
Attribution Total
Pearson
Correlation
P value
N
Attribution
Percentage
Pearson
Correlation
P value
N

White
.244**

Black
-0.027

Asian
-0.047

Hispanic
-0.004

Native
American
0.012

Other Race
.167*

NonWhite
0.014

0.004
140
Percent
White
.416**

0.756
140
Percent
Black
-.365**

0.578
140
Percent
Asian
-0.134

0.967
140
Percent
Hispanic
-.222**

0.887
140
Percent Native
American
-0.136

0.049
140
Percent
Other Race
-0.069

0.871
140
NonWhite
-.416**

0.000
140

0.000
140

0.114
140

0.008
140

0.109
140

0.420
140

0.000
140

Note. CRC = colorectal cancer
Linear Regression
I used linear regression to further analyze the correlations between ACO #19
performance and the number of patients in an ACO for each age category. The
relationship was statistically significant (F(4,135) = 5.84, p<.05).The total patients in
each age group attributed to the variance in ACO #19 performance by 14.8% with an R2
value of .148 and an adjusted R2 of .122.
ACO #19 score increased slightly as the total number of patients between the age
of 75-84 increased with a coefficient of B = .002. Scores also increased with a coefficient
of B = 7.11 as the number of patients between the age of 65-74 increased. There was a
slight decrease in performance with B = -.002 as the total number of patients between 064 years old and over 85 years old increased.
The relationship between the percent of patients in each age group and ACO #19
performance was statistically significant (F(3,136) = 16,650,p<.05).These percentages
had a higher influence of 26.9% of the variance with an R2 of .269 and an adjusted R2 of
.252. ACO performance increased B = .311 as the percent of patients in the ACO
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increased between the ages of 65-74 years old. Performance also increased B = 1.27 as
the percent of patients increased between the age of 75-84 years of age. However,
Performance decreased B = -.509 as the percent of patients 85 or older increased.
I used linear regression to further analyze the correlations between ACO #19
Performance and race. The relationship was statistically significant (F(11,128), p<.05).
Race attributed to the variance in performance by 27.2 % with an R2 value of .272 and an
adjusted R2 of .210. ACO #19 performance improved with B = 6.4 as the number of
White patients increased. Performance decreased slightly B = -.001 as the number of
patients categorized as “Other” increased. Performance decreased B = -.804 and B = .420 as the percentage of Hispanic and Black patients increased respectively.
Discussion
Interpretation
Almost 25% of adults between 76 and 84 did not meet the U.S. Preventative
Services Task Force recommendations for CRC screening before the advent of Medicare
ACOs (Klabunde et al., 2015). My findings showed that only four out of 470 ACOs did
not meet the minimum performance score of 30 for ACO #19. However, 36% of the 140
target ACOs scored under 70%.
My overarching study showed the size of the ACO attribution had a statistically
significant correlation to ACO #19 performance. This aligned with previous research that
practice size as defined by the number of patients predicted success with CMS quality
measurements (Greene et al., 2015). Results also supported compliance disparities
between races (Ashktorab et al., 2017; Bromley et al., 2015; Burnett-Hartman et al.,
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2016; Chablani et al., 2017), as I found a statistically significant correlation that more
Black and Hispanic patients in an ACO resulted in lower performance scores. This
aligned with previous studies where non-White patients were less likely to complete CRC
screening (Basch et al., 2016; Bromley et al., 2015; Hall et al., 2016; Kiviniemi et al.,
2018; Klabunde et al., 2015; Mastrokostas et al., 2018). Thus, ACOs that serve high
numbers of minority patients experience lower quality performance than others (Lewis et
al., 2017). This may correlate to research that showed lack of trust to be a contributing
factor behind non-compliance of CRC screening for many Hispanic patients (Hong et al.,
2018).
In addition to race, my study found statistically significant differences for ACOs
with different age categories. This further supports findings of unconscious bias by
providers when treating patients of different race, age and socioeconomic groups.
(Williams et al., 2015). Other studies, however, found no relation to these characteristics
and provider decisions (Haider et al., 2015). My study did not show a difference in ACO
#19 performance based on gender. However, caution should be made when generalizing
these results as they were not calculated at the individual patient or provider level.
Interpretation in the Context of the Socioecological Model
My study was guided by the SEM. Under the SEM, provider performance is
affected by factors that influence both their decision making and their effectiveness to
change patient behavior (Rabarison et al., 2013). My study showed that participation in
an ACO and practice size as total patients and number of minorities may influence
provider effectiveness to change patient behavior. Furthermore, factors related to the
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characteristics of their patients may influence their effectiveness. Society/policy factors
tied to creating ACOs and their CMS quality measurements (i.e., success defined by a
score of at least 30 for ACO #19) are also influential. My research did not report findings
related to socioeconomic make up. However, my overarching research demonstrated that
a high percentage of patients with lower socioeconomic status negatively influence
provider effectiveness.
Limitations
There are limitations to my study. First, I excluded new ACOs from the full
analysis. Thus, the range of performance of the sample population (n = 140) may not
reflect the distribution of the entire ACO base (n = 470). Nor may it reflect provider
patient relationships for providers and patients that do not participate in ACOs. Caution
should be used when generalizing these results for other applications. Second, the MSSP
PUF file data are restricted to the variables within the data set. The file does not provide
CRC screening results at the individual level for patients or providers. Thus, my findings
are limited to generalizations about ACOs based on total number of providers, total
number of patients, and percentages of patients with certain characteristics. As a result, I
am unable to articulate differences in ACO #19 compliance at the individual patient and
rely instead solely on the ACO #19 performance score. I am also unable to articulate
difference at the individual provider level. Lastly, the MSSP PUF has a one-year delay in
reporting. The results were provided before the significant change in care delivery due to
the COVID-19 pandemic and may influence the generalizability for future applications.
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Implications
Cancer screening rates have declined due to the COVID-19 pandemic (Carethers
et al., 2020). The COVID-19 pandemic disproportionality affected minority communities
and further resulted in even lower screening rates for minority populations (Carethers et
al.). As such, Carethers et al., posit that extended delays in cancer screening is expected
to lead to increase cancer for all populations. This is expected to be elevated in minorities
and lower socio-economic people. My study offers insight as to which populations may
be at greater risk based on their previous experience with CRC screening before the
pandemic.
My findings supported previous research that showed disparities among nonWhite patient populations. It further demonstrated a lack of compliance with CRC
screening where more patients in the population were either under 65 or over 85 years
old. My research helps to decrease the prevalence of CRC and by doing so reduce the
economic and quality of life burden for individuals and communities affected by the
disease. Moreover, my study helps to reduce disparities for CRC screening and incidence
of CRC among vulnerable populations.
My study promotes positive social change by providing a foundation for
population health initiatives beyond CRC related illness Thus, improving the wellbeing
of communities and increase public health emergency preparedness. It provides
meaningful data to the public health and health care provider partnerships engaged in
transforming healthcare from a transactional delivery system to an evidence-based system
of value (Berenson et al., 2016). It will influence policies that support health and wellness
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initiatives in communities of color and patients aged 65 year and older. ACOs are
partnerships among care providers including public health organizations. My study can
improve public health and healthcare professionals’ ability to influence the behaviors and
health outcomes of the community members they serve. This is a vital component of
current efforts to screen for COVID-19, promote adoption of behaviors to slow the spread
of COVID-19 and adoption of COVID-19 vaccinations. The CMS (2012) stated that
more than 70% of patients over the age of 65 have two or more chronic conditions. The
management of patients with multiple chronic diseases is more difficult than in those
suffering from a single condition (Wagner et al., 2013). Wang et al., observed (2020) that
elderly COVID-19 patients were among the most severe to critical cases with a high rate
of fatality. Thus, the results of my study apply to current efforts for high risk elderly
patients, their providers and communities.
Lastly, my study can offer guidance to public health and healthcare provider
leaders on ways to train professionals better, reduce frustration, improve success and
achieve higher levels of satisfaction in their work both in routine interventions and public
health emergencies.
Recommendations
Several recommendations resulted for additional research from my study.
Additional analysis should be conducted for further assessment of ACO #19 performance
based the size of the ACO population and the number of providers participating in an
ACO. The influence of insurance coverage particularly for lower socio-economic patients
with Medicaid should be explored. Next, some CRC screenings are complex. These
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include tests some which have multiple compliance steps like those with colonoscopy
screening. This contrasts with dichotomous behaviors like receiving a flu-vaccination. I
recommend future studies to compare complex behaviors such as CRC screening with
dichotomous decisions like receiving an influenza vaccination.
The study should also be replicated for all 470 ACO participants. This may
provide insight on differences and similarities to new and experienced ACOs. Future
research could include provider feedback using tools like the primary care provider
Behavioral Health Intervention Survey. The original tool was designed to assess provider
perceptions of factors that influence their intention to use interventions when treating
children with mental health problems and can be modified for adults (Arora et al., 2016).
Lastly the study could be replicated and expanded as a mixed methods
explanatory sequential study. Mixed methods integrates open-ended qualitative data with
closed-ended quantitative data from inquiry (Creswell, 2009). Mixed methods strategy is
purpose-driven research to provide a more in-depth insight into how health professionals
influence participant behavior (Creswell, 2009). Mixed methods can develop a more
comprehensive understanding of changes needed for population engagement as well as
understanding the process and outcomes of current patient engagement strategies
(Creswell, 2009).
Conclusion
Health care delivery and public health have overlapping efforts like health
screening activities for better health outcomes and to lower the burden of disease
(Cunningham et al., 2020). Partnerships between community-based organizations, health
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care delivery and public health organizations improve public health outcomes. Studies
showed patient behavior was the key to improve quality and health outcomes (Mogre et
al., 2019).
The MSSP ACO is partnership based advanced payment model designed to curb
cost and improve patient outcomes for colon cancer among other disease measures. CRC
is a leading cause of death in the United States, (Loyd, 2016) and more research is needed
to determine the impact of MSSP ACO providers on CRC screening. Previous research
found disparities in health behavior recommendation compliance among people based on
patient base characteristics race, age and gender.
My quantitative study of 140 ACO participants sought to determine the
relationship between these patient characteristics and compliance with MSSP
performance measure for colonoscopy screening ACO #19. My findings correlate with
previous research around physician influence on paitent behavior and patient compliance
with physician recommendations. My findings showed differences in performance based
on age and race but not for gender. Performance increased for ACOs with more patients
between the age of 65-85 years old. However, performance declined as the number and
percentage of non-White patients increased. This aligned with previous research which
showed disparities exist across socioeconomic and racial/ethnic boundaries. The results
did not show a difference in performance based on the gender makeup of the ACO
population.
My study addressed the gap in research and focused on participant behavior of
ACOs based on the racial, gender and age distribution of their patient populations. It
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contributes to positive social change by providing meaningful data to public health
partnerships and policy makers as to how these social determinants of health impact
outcomes. Therefore, the application of my findings can improve the ability of public
health and healthcare providers to predict their influence on behavior and health
outcomes of the community members they serve. Furthermore, it supports policies and
processes around cultural awareness and cultural competencies to contribute to better
healthcare delivery.
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Provider Influence on Patient Behavior Related to Population Insurance Coverage

Harry Petaway

Walden University

Objective: This study assesses the preventative quality performance measure (ACO #19)
for colon cancer screening under Medicare Shared Savings Plan ACO guidelines. I
quantified the overall performance of ACO #19 based on the population’s demographics
of race, age, and gender.

Methods: A cross-sectional quantitative study was conducted for organizations who
participate as a Medicare Shared Savings Plan Accountable Care Organization. The
research included secondary data analysis of the 2019 Medicare Shared Savings Plan
PUF on quality performance.
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Abstract
Public health efforts to improve health include vaccination and screening initiatives to
reduce the burden of disease. This study focused on colorectal cancer (CRC) screening
behaviors of accountable care organization (ACO) patients with Medicaid and providers’
ability to comply with the Medicare Shared Savings Plan (MSSP) quality measure ACO
#19. This study used the socioecological model and a cross-sectional quantitative design
to assess data from the MSSP public use file 2019 to expand on current literature that
determined Medicaid patients experienced bias and obstacles while pursuing CRC
screening. Furthermore, it supported previous research that patient behavior was the
primary driver to improve healthcare quality and reduce costs. This study found ACOs
with more Medicaid patients were also less successful with less Medicaid distribution.
Success with CRC screening is influenced by factors like policies, funding sources, and
external demands that guide decisions. Moreover, rising costs of the United States
Healthcare system is a public health threat. This study contributes to positive social
change by providing meaningful data to public health partnerships and policies that
impact community health outcomes for lower socio-economic patients. The implications
for positive social change in this study include data for policy makers, health, and public
health care professionals to reduce disparities for CRC screening and incidence of CRC
among vulnerable populations. Therefore, the application of my findings can improve the
ability of public health and healthcare providers to predict their influence on behavior and
health outcomes of the Medicaid beneficiaries they serve. The data also supports
population health initiatives beyond CRC-related illness.
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Introduction
Healthcare costs in the United States are rising at an unsustainable rate and
include significant disparities in health outcomes attributed to social determinants (Foo et
al., 2017; Noble et al., 2014). Public health agencies and clinical health organizations
formed partnerships in several communities to form new public healthcare delivery
models (Noble et al., 2014). These partnerships were designed to improve their
population’s health by influencing individual behavior and addressing social
determinants of health (Bachrach et al., 2016; Noble et al., 2014). For example, the
Institute of Healthcare Improvement’s Quadruple Aim outlined a framework to improve
health outcomes, lower healthcare costs, improve patient experience, and improve
clinician satisfaction (Wagner et al., 2018). This contributed to the development of
experimental alternative payment delivery models (APMs) to achieve components of the
Quadruple Aim; however, these new designs have had varying degrees of success (Noble
et al., 2014). Studies have shown that population engagement is essential to guide
community members toward behaviors that lead to healthier outcomes, which could
reduce the overall cost of care (Grand et al., 2014). However, there was little evidence of
which strategies were most successful at influencing the population’s behavior.
Problem
Patient behavior is the key to improve health quality and outcomes, yet many
physicians have found it difficult to influence individual behavior (Hibbard et al., 2015).
Moreover, researchers have found disparities in patient compliance with health behavior
recommendations (Kiviniemi et al., 2018; Manteuffel et al., 2014) linked to patient
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characteristics and provider variables like the size of provider practices (Kiviniemi et al.,
2018; Manteuffel et al., 2014). Data on the patient experience are captured in
performance reporting through the Centers for Medicare and Medicaid Services (CMS,
n.d.). Furthermore, patient perspectives toward patient engagement are well documented
in the literature (Rowland et al., 2017). However, provider experiences, perceptions,
success, and strategies to engage community members attributed to their APMs have not
been represented in previous research (Andrealli et al., 2018; Bekmuratova et al., 2019;
Berenson et al., 2016; Chen et al., 2016). Thus, there is an inability to replicate the best
practices for population engagement, that improve participant experiences, job
satisfaction, health outcomes, and lower costs. This manuscript addressed a gap in
research and focused on the relationship of the population demographics race, age and
gender and providers’ influence on APM patient behavior. I explored the preventative
quality performance measure for colon cancer screening ACO #19 for the Medicare
Shared Savings Plan (MSSP) ACO guidelines.
Significance of the Study
ACOs introduced patient engagement initiatives to lower the U.S. healthcare costs
with different levels of success (Noble et al., 2014). Some ACO populations include
underserved and vulnerable patients who are covered by both Medicare and Medicaid
(Powers & Keohane, 2018). Abundant data on health care quality are captured by CMS
performance reports (CMS, n.d.). The literature, however, has not shown evidence as to
why providers were successful at influencing patient behavior. Disparities for
preventiative care and health outcomes exist for people with different insurance types
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(Kiviniemi et al., 2018). Davis et al. (2017), demonstrated that lower socioeconomic
patients and Medicaid patients experienced bias when they pursued CRC screening.
However, provider perceptions and their experience of engaging patients attributed to
their APMs have not been explored in detail (Hibbard et al., 2015). One application of
this rationale was shown in a study of an emerging United Kingdom healthcare model in
which providers were paid incentives to develop patient focus groups with the intention
of a community-based participatory approach to improve provider care delivery (Smiddy
et al., 2014). Smiddy et al., (2015) proved that financial incentives increased the number
of focus groups but found little impact on the quality of care delivered. Smiddy’s model
(2015) applies to my study as exploring provider experiences managing patient
populations with Medicaid or lower socio-economic status might explain to what degree
they effect patient behavior compared to the measures that determine their payments. My
study found that ACOs with higher numbers of Medicaid patients had lower CRC
screening rates.

Relevant Contribution to the Body of Knowledge
This manuscript is the first of three manuscripts to a cross-sectional quantitative
study to explore the preventative quality performance for colon cancer screening under
MSSP ACO guidelines. My broader study explores how patient demographic
characteristics race, age, gender, and insurance coverage predict performance. This
manuscript fills a gap in research by focusing on provider practice characteristics. My
cross-sectional study provides a more comprehensive assessment of physician influence
on patient behavior than studies like those from CMS. The purpose of my study was to
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assess the relationship between patients’ insurance coverage and provider effectiveness at
influencing patient behavior as measured by the compliance of MSSP performance
measure ACO #19.
Framework
The socioecological model (SEM) guides my cross-sectional quantitative study. I
assessed data from the MSSP public use file (PUF). Under the SEM, provider
performance is affected by factors that influence both their decision making and their
effectiveness to change patient behavior (Rabarison et al., 2013). SEM posits five
categorical levels which affect behavior change (Lampard et al., 2013). These levels
include the individual, interpersonal, organizational, community/environment, and
society/policy levels (Lampard et al., 2013). While the factors of the SEM are
hierarchical, they are also integrated, and a change in one area could impact others
(Coreil, 2009).
The positivist ontology also guides my study. Positivism implies that there is a
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment
through a PUF. Thus, these results reflect a single truth of their performance. My study
assessed how insurance coverage predicts how effective providers are at achieving ACO
#19 measure attainment. My findings are the source of truth under the positivist ontology
for my study
My study is influenced by multiple contexts. The personal contexts for my study
include my knowledge and experience with advance payment models and patient
engagement. The social contexts include CMS guidelines, the fluidity of US healthcare
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policy, political climate, geographic locations, and local healthcare delivery priorities.
Lastly, interpersonal contexts include Walden University dissertation committee
representatives.
The definition of “provider success” is precise and supports a quantitative
ontology of positivism where there is one true reality (Burkholder et al., 2016).
Positivism guided my cross-sectional quantitative study to answer the question; “How
effective were providers at influencing patient behavior based on the performance
measure ACO #19 of the Medicaid Shared Savings Plan?”. I analyzed archival data from
the CMS to support the positivist approach to my research question (Burkholder et al.,
2016).
Background
Colorectal cancer (CRC) is a leading cause of death in the United States (Lloyd,
2016). The Centers for Disease Control and Prevention estimated over 40,000 deaths
attributed to colon cancer in 2016 (Bachman et al., 2018). The risk of CRC mortality can
be reduced with early detection (Lloyd, 2016). Focused efforts to increase CRC screening
led to a reduction of CRC related deaths in the last decade; yet, several disparities
continue to exist across socioeconomic and racial/ethnic boundaries (Bromley et al.,
2015). Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did
not meet the U.S. Preventative Services Task Force recommendations for CRC screening
before the advent of Medicare ACOs.
APMs were created to fight rising health care costs in the United States (Noble et
al., 2014). ACOs are one of the advanced payment models designed to shift the focus of
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healthcare services from a traditional fee for service structure to a value-based care
model. CRC screening is a key focus and measurement of ACOs. The propensity for
provider recommendations for appropriate screening based on the Preventative Services
Task Force recommendations for CRC screening was very low before the advent of
Medicare ACOs (Klabunde et al., 2015). Studies showed that socioeconomic status was a
patient characteristic and determinant of CRC screening completion (Farrukh &
Mayberry, 2019).
Some ACO populations include underserved and vulnerable patients who are
covered by Medicaid in addition to their Medicare coverage (Powers & Keohane, 2018).
Researchers found that Medicaid patients experienced bias when they pursued CRC
screening (Davis et al., 2017). For example, Nymo, Aabakken, and Lassen (2018)
reported that Medicaid patients experienced longer wait times when they scheduled CRC
screening procedures whereas more affluent patients were prioritized to enhance their
patient experience and satisfaction. Thus, providers must be aware of both intentional and
unintended bias when working with patients from different cultures and socioeconomic
groups (Alspach, 2018). Other studies, however, suggested Medicaid patients received
more opportunities for CRC screening as care coordination improved for dual eligible
patients (Craver et al., 2018). In fact, Davis and colleagues (2019) found evidence that
CRC screening increased for Oregon Medicaid patients who were enrolled in an ACO.
However, their research observed an ACO structure designed exclusively for Medicaid
patients (Davis et al., 2019). Evidence also showed that more ACOs were more likely to
have formal partnerships with public health agencies where there were large numbers of

119
Medicaid patients and where residents were eligible for both Medicare and Medicaid
(Costich, Scutchfield, & Ingram, 2015)
Research further documented disproportionate racial and socioeconomic
disparities and highlighted the diverse cultural requirements needed to influence patient
behavior (Ashktorab et al., 2017; Bromley et al., 2015; Burnett-Hartman et al., 2016;
Chablani et al., 2017). Many studies offered anecdotal patient interventions for patients
not enrolled in APMs (Nathan et al., 2016; Singal et al., 2017; Slyne et al., 2017).
Additionally, studies that focused on non-APM patient experiences reinforced culturally
competent approaches based on diverse patient demographics (Alsayid et al., 2019;
Brittain & Murphy, 2015; Chen et al., 2016).
Fear was demonstrated to be a major influence for compliance by all patients, but
particularly among blacks and Hispanics (Basch et al., 2016; Bromley et al., 2015; Hall et
al., 2016; Kiviniemi et al., 2018; Mastrokostas et al., 2018). Fear emerged as fear of both
fear of undergoing the procedure and fear of the procedure’s findings (Bromley et al.,
2015). Ineffective communication and perceived provider uncertainty also affected the
patient decision-making process (Beverly et al., 2016). This was confounded by patients’
expectations of the provider (Alspach, 2018; Mast & Kadji, 2018). For example, patients
with different socio-economic backgrounds had different expectations of the quality of
care they should receive from providers (Mast & Kadji, 2018). As such, trust was
demonstrated to be a contributing factor behind non-compliance of CRC screening for
Hispanic patients and patients of lower socio-economic status (Hong et al., 2018). Studies
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also showed unconscious bias by providers when treating patients of different
demographics and socioeconomic status (Williams et al., 2015).
Medicare recognizes four methods of colonoscopy screening to demonstrate
compliance with the ACO #19 measure (Prince et al., 2017). These include colonoscopy,
DNA, stool testing, and fecal occult blood test. Studies suggest CRC compliance varies
with the type of test offered, Thus, could impact the CRC screening recommendations
that providers make to their patients (Alsayid et al., 2019; Basch et al., 2016; Bian et al.,
2016; Brenner & Chen, 2017; Bromley et al., 2015; Chambers et al., 2016).
Colonoscopy is the most popular forms of CRC screening, and includes multiple
steps like scheduling, bowel preparation, sedation, and the procedure itself; some of
which contain multiple levels of compliance (Powers et al., 2018). For example,
strategies such as enhanced written education, media campaigns, and videos improve
compliance with the bowel preparation step (Andrealli et al., 2018; Cole et al., 2019;
Essink-Bot et al., 2016). However, they were demonstrated as less effective to improve
patient health literacy and compliance for completing a colonoscopy procedure (Clark et
al., 2017; Enard et al., 2015; Mishra et al., 2018).
Success varied among the experimental APMs in the United States (Noble et al.,
2014). Hibbard et al. (2015) documented that compensation from APMs in other
countries influenced physician opinions on the importance of patient behavior. They
further provided evidence that patient behavior was the primary driver of improving
quality (Hibbard et al., 2015). Other studies showed that improvements in patient
engagement lead to better health outcomes (Simmons et al., 2014; Grand et al., 2014).

121
Physicians in the United States agreed that patient behavior was the key
determinant to improve quality and outcomes, yet, many found frustration when they
tried to influence individual behavior (Hibbard et al., 2015). While many providers
perceived their role within the community and in population health as “medicine-based”;
a growing emphasis on preventative care and the diverse characteristics of their attributed
patient base fostered better collaboration between healthcare providers and traditional
public health organizations (Ingram et al., 2015). This was particularly true for mutual
objectives like cancer prevention or serving a large number of Medicaid patients (Basch
et al., 2016; Ingram et al., 2015).
Nywelde et al. (2015) showed the initial performance under the Medicare ACO
model reduced healthcare expenditures within the attributed population base when
compared to traditional Medicare fee-for-service beneficiaries. The CMS measures ACO
providers across four domains, which include care coordination, patient safety, patient
experience, and preventative health (Modi et al., 2018). Providers are rewarded for the
decreased cost of patient care as well as achieving various quality metrics outlined in
their ACO contracts.
Studies documented provider perceptions of barriers and provider characteristics
that influenced their decision making and level success (Mastrokostas et al., 2018; Wang
et al., 2018). These included the basic ability to verify patient’s correct CRC status and
the clinician’s ability to confer with specialists (Mastrokostas et al., 2018) For example, a
provider recommendation is a primary influence on whether patients of all demographic
groups participate in CRC screenings (Bian et al., 2016; Bromley et al., 2015). Some
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studies showed that health information technologies that shared patient information,
insurance information and alerted providers to the patient’s CRC risk or screening status
nudged providers to provide CRC screening recommendations (Kim et al., 2017b;
Mankaney et al., 2019). Additionally, other studies reiterated the importance of Patient
Behavior on quality performance and the need to implement systems to support patient
engagement activities to influence behavior (Mishra et al., 2018). These included the
concepts of, motivational interviewing, goal setting, and shared decision making (Mishra
et al., 2018). However, Mishra et al. (2018) reported that providers were aware of these
concepts but often lacked the depth of understanding and practice to implement them in a
meaningful way. Shapiro et al. (2018) further described provider experiences with tough
to manage patients in which providers described themselves as anxious, frustrated, and
uncertain with little preparation for how to handle difficult patients. My study fills a gap
in research by focusing on the patient insurance coverage to achieve compliance with
CRC screening recommendations.
Research Question and Design
The nature of the manuscript is a cross-sectional quantitative study for the
following research question:
Based on the performance measures of the MSSP, what is the relationship
between insurance and compliance of MSSP performance measure ACO #19?
H0: There are no statistically significant differences in behavior as measured by
the compliance of MSSP performance measure ACO #19 based on insurance coverage.
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Ha: There are statistically significant differences in behavior as measured by the
compliance of MSSP performance measure ACO #19 based on insurance coverage.
The rationale for these research questions are based on a series of assumptions.
First, there are outcomes related to patient behavior that are reported by CMS. Second,
there are outcomes related to patient behavior that are perceived by physicians (Ravitch
et al., 2016). Third, success can be measured through CMS reporting (CMS, 2017).
Cross-sectional quantitative studies are descriptive research to describe
community characteristics at a single point in time. I analyzed data from the MSSP PUF
from 2019. I assessed the relationship of dependent variable ACO performance for
measure ACO #19 and the independent variable patient insurance.
Methods
Operational Definitions
ACO #19: Percentage of adults between 50–75 years of age who had appropriate
screening for CRC for ACO quality reporting (CMS, 2017).
Alternative payment delivery models: Several experimental advance/APMs have
been created with varying success to introduce new patient engagement initiatives to
combat higher U.S. healthcare costs (Noble et al., 2014).
Attribution: The patients assigned to the health care provider for which they are
being measured (Noble et al., 2014).
Patient engagement: Studies show that improvements in patient engagement lead
to better health outcomes (Simmons et al., 2014).
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Practice size: The number of patients and the number of primary care physicians
in an ACO.
Bias and Limitations
I analyzed archived data from the CMS; therefore, the quality of this quantitative
data source was beyond my control as the researcher and contingent on the data
collection process for MSSP reporting (Burkholder et al., 2016). CMS (2017) allows
providers to review and dispute published performance data, followed by a final CMS
ruling. I used the final report issued by CMS which included corrections to improve data
quality. I coalso uld not control confounding variables that may influence providerpatient attribution (Noble et al., 2014). These included patient comorbidities that can
affect patients abilities to comply with healthcare treatment plans (DeJean et al., 2013).
Scope and Delimitations
The MSSP ACO PUF details physician performance against 32 measures across
four domains (CMS, n.d.). The results are the official CMS findings and used to pay
provider incentives (Noble et al., 2014). Therefore, these measures are valid
representations of physician performance. The scope of my study was to evaluate
physicians’ performance against the CMS measurement for colon cancer screening “ACO
#19”.
I limited my target population to the subset of organizations that had previous
experience with MSSP ACOs and those who reported data for the 2019 MSSP reporting
year. Excluding first-year MSSP participants improved credibility by ensuring that
providers in the sample had a baseline measurement that reflected their performance
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better (Noble et al., 2016). Foo et al. (2017) showed disparities in provider-patient
interactions may be influenced by the factors race and patient insurance coverage.
Therefore, a third delimitation limited the participatn sample to those with a patient base
with at least 10% non-White and accept both Medicaid and Medicare patients (CMS,
2017). Succesful attainmnet of ACO #19 was detrmined by a score of at least 30% (CMS,
2017). I differentiated well-performing providers from poor performing using this
recognized benchmark as a fourth delimitation (CMS, 2017).
Design
Positivism guided the cross-sectional quantitative study to answer the question,
“How effective are providers at influencing patient behavior based on the performance
measure ACO #19 of the Medicaid Shared Savings Plan?” Archival data analysis from
the CMS 2019 MSSP PUF supported the positivist approach to my research question. I
used the quality performance data for healthcare providers reported in the PUF to
determine their effectiveness at influencing patient behavior as it correlated to their
practice size.
Instrumentation
Archival data from the MSSP PUF for 2019 was used for the data collection
process. The MSSP ACO PUF was derived from a combination of provider claims and
survey data. The PUF files are available for performance years 2013-2019. The PUF file
included hundreds of variables, descriptions and performance measure outcomes. These
included measures for six behavior related preventative measures. Performance measures
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were captured as a percent of the total population where a higher score means higher
performance for that measure.
Provider incentives for MSSP ACOs were based on quantitative analysis of their
performance against established benchmarks (Noble et al., 2014). As such the current
reporting for the effectiveness of APMs is dichotomous as the providers did or did not
meet their measurement objectives (CMS, n.d.). This clear determination of provider
success supports a quantitative ontology of positivism in which there is one true reality
(Burkholder et al., 2016). Furthermore, quantitative analysis of provider performance
using MSSP public use data is an accepted practice among the healthcare community
(Noble et al., 2016).
Participants
I limited the evaluation of provider performance to organizations in the United
States who had previous ACO experience prior to 2019 and who reported data for the
2019 MSSP reporting year. Previous studies showed that providers treated patients
differently according to sociodemographic characteristics (Foo et al., 2017; Manteuffel et
al., 2014). Therefore, I restricted participants to ACOs with a patient base of at least 10%
non-White and who accepted both Medicaid and Medicare patients. Furthermore, CMS
set a minimum standard of 30% achievement to comply with MSSP guidelines.
Therefore, participant selection was based on provider performance compared to the
30% benchmark.
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Data Sources
Archival data was reviewed from the MSSP PUF for 2019. I used data for new
and returning ACO participants from the 2019 MSSP PUF. I described the extent that
ACOs were successful with measure ACO #19. I uploaded the entire MSSP PUF
database into SPSS v25 for review, analysis, and statistical testing.

Quantitative Collection and Analysis
I assessed how effective ACOs were at changing patient behavior. I described the
extent that ACOs were successful at achieving colon cancer screening for measure ACO
#19. I uploaded the entire 2019 MSSP PUF database into SPSS v25 for review, analysis,
and statistical testing. I retained the native MSSP PUF document, which was uploaded
multiple times with all statistical tests replicated to ensure integrity and reliability. I used
Pearson Correlation and linear regression to determine if there was a significant
relationship between ACO practice size and performance. The level of significance was
set to 0.05.
Results
Based on the performance measures of the MSSP, what is the relationship
between insurance coverage and compliance with MSSP performance measure ACO
#19?
H0: There are no statistically significant differences in compliance with MSSP
performance measure ACO #19 based on insurance coverage.
Ha: There are statistically significant differences in compliance with MSSP
performance measure ACO #19 based on insurance coverage.
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Execution
Archival data from the MSSP PUF (CMS, n.d.) for 2019 were assessed for 470
ACOs. I calculated an additional variable to reflect the percentage of the total population
by race, age, gender, and Medicaid status in Microsoft Excel. The modified file was then
entered into SPSS version 25 to organize, code, and screen data. Data for ACO #19 score
and practice size were recoded to ordinal categorical data. Values were calculated
including frequency counts and percentages with SPSS. Descriptive data analysis was
performed for frequencies for all ACOs.
The final sample size was narrowed to 140 ACOs based on the inclusion and
exclusion criteria for the study. These included previous experience in the MSSP
program and an ACO #19 score of 30 or more, an attribution that was at least 10% nonWhite. I performed statistical assumption tests for normal distribution, homoscedasticity,
and linearity between dependent and independent variables before research question
analysis. Table 14 summarizes the dependent, independent variables, and statistical
analyses used to evaluate the research questions.
Table 14
Variables and Statistical Tests Used to Evaluate Research Questions
Research Question
What is the relationship
between insurance and
compliance with MSSP
performance measure ACO
#19?

Dependent
Variable

ACO #19 Score

Note. ACO = accountable care organization

Independent Variable
Number of Medicaid Patients
Percent of Medicaid Patients

Analysis
Pearson
Correlation
Linear
Regression
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Descriptive Statistics for all ACOs
Descriptive analysis for all (n = 470) ACOs and the target sample (n = 140) were
conducted for ACO #19 performance and insurance. Table 15 shows the ACO #19
performance with most organizations achieving between 50% and 90%. Performance for
the target population aligned with the larger base with most organizations (n = 85)
achieving between 70–89% followed by those between 50–69% (n = 47).
Table 15
ACO #19 Performance Range and Frequency
ACO #19 Score
0-29
30-49
50-69
70-89
90 to 100
Total

All ACOs
Frequency Percent
4
0.9
13
2.8
157
33.4
287
61.1
9
1.9
470
100.0

Target ACOs
Frequency Percent

Note. ACO = accountable care organization

4
47
85
4
140

2.9
33.6
60.7
2.9
100.0

Most ACOs had less than 200 primary care providers with the majority falling
between 50–99 at roughly 22%. ACOs that did not report a score for ACO #19 (n = 4)
were removed. Of the remaining (n = 466) there was a total of 9,918,470 patients. Table
16 shows beneficiaries with Medicaid totaled 606,989 or six percent of total patients. The
number of patients with Medicaid ranged from 67-17,981.
Table 16
Range and Percentage of Attribution Across all ACOs
Total Patients
Medicaid Patients
Non-Medicaid Patients

Minimum
2,193
67
1,346

Maximum
239,924
17,981
181,135

Sum
9,918,470
606,989
7,917,736

Percent
6%
80%
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The attribution of most ACOs in the target population was under 40,000 patients.
Table 17 shows that over half of the ACOs carried an attribution of between 10,000 and
39,999 followed by a range of 2,193 to 9,999 (27%).
Table 17
Range and Percentage of Attribution
Attribution Range
0-9,999
10,000-39,999
40,000-79,999
80,000 or more
Total

Frequency
38
77
19
6
140

Percent
27.1
55.0
13.6
4.3
100.0

Tests of Assumptions
I conducted assumption tests of the dependent variable ACO #19. The data were
normally distributed and follow a normal distribution curve. The skewness and kurtosis
tests for normal distribution should fall between the rage of ±2 and ±7 respectfully. The
ACO #19 score data for skewness was -.287 and kurtosis was -.692. The KolmogorovSmirnov test for normality was insignificant at .058. Figure 5 shows the normal Q-Q plot
of the data.
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Figure 4
Normal Q-Q Plot for ACO #19 Performance

Note. ACO = accountable care organization
Inferential Statistics
The Medicaid.gov website (2021) defines Medicaid as insurance coverage
provided by states according to federal requirements for eligible low-income patients and
people with disabilities. I found that insurance coverage of patients in an ACO statically
influenced ACO #19 performance. Therefore, the null hypothesis that there was no
relationship between insurance and ACO #19 performance was rejected. I used bivariate
correlation to assess the relationship between the dependent variable ACO #19
Performance and independent variables for insurance (Medicaid). These included the
total of Medicaid patients and the percentage of Medicaid patients of the total population.
Table 18 shows the number of non-Medicaid patients in an ACO had a positive
correlation of .247 that was statistically significant with p = .003. The percentage of
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patients in the ACO had negative correlation of -.357 that was statistically significant
with p<0.05.
Table 18
Correlation Between Medicaid and ACO #19 Performance

ACO #19
Performance

Pearson
Correlation
P value
N

1

Medicaid
Patients
-0.096

Non-Medicaid
Patients
.247**

Medicaid
Percent
-.357**

140

0.259
140

0.003
140

0.000
140

Note. ACO = accountable care organization. **. Correlation is significant at the 0.01
level (2-tailed).
Medicaid only accounted for six percent of the total (n = 466) of the total
population. However, figure six shows ACOs in the target sample (n = 140) with higher
percentages of Medicaid patients performed lower than those with less.
Figure 5
ACO #19 Score and percent of Medicaid

Note. ACO = accountable care organization
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Linear Regression
I used linear regression to further analyze the correlations between ACO #19
Performance and levels of insurance coverage within the ACO population. The
relationship was statistically significant (F(3,136) = 8.12, p<.05). Insurance accounted
for a 15.2% variance in ACO performance and an adjusted R2 of .133. ACO performance
decreased B = -.001 as the number of Medicaid Patients in increased. Performance
decreased by B = -.228 as the percent of Medicaid patients in the ACO increased.
Discussion
Interpretation
My research correlates with previous research around physician influence on
paitent behavior and patient compliance with physicina recommendations. For example,
Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did not
meet the U.S. Preventative Services Task Force recommendations for CRC screening
before the advent of Medicare ACOs. My findings showed that only four out of 470
ACOs did not meet the minimum performance score of 30 for ACO #19. However, 36%
of the 140 target ACOs scored under 70%.
The first ACOs showed an increase in CRC screening for patients 65 years or
older when compared to non-ACO patients or the start of the ACO model (Preston et al.,
2018); however, significant disparities for screening rates were found between White and
Black or Hispanic ACO members (Bromley et al., 2015). Additionally, the trend to
improve quality measures has not applied to ACOs in underserved communities nor
among racial disparities (Bromley et al., 2015). My overarching study found that ACOs

134
with more Black and Hispanic patients did not perform as well for ACO #19. Other
researchers have also found disparities in compliance among people with health behavior
recommendations based on factors including insurance coverage (Kiviniemi et al., 2018;
Manteuffel et al., 2014).
Additionally, I found that higher numbers and percentages of Medicaid patients
negatively affected ACO #19 performance. Medicaid is insurance coverage for eligible
low-income patients. Thus, high number of Medicaid patients could indicate lower
socioeconomic status of the ACO attribution. But caution should be made when
generalizing these results as they were not calculated at the individual patient or provider
level.
Interpretation in the Context of the Socioecological Model
My study was guided by the SEM. Under the SEM, provider performance is
affected by factors that influence both their decision making and their effectiveness to
change patient behavior (Rabarison et al., 2013). My study showed that participation in
an ACO and practice size as total patients and number of minorities may influence
provider effectiveness to change patient behavior. Furthermore, results demonstrated that
factors related to the characteristics of their patients influences their effectiveness.
Society/policy factors tied to creating ACOs and their CMS quality measurements (i.e.,
success defined by a score of at least 30 for ACO #19) are also influential. My study did
not report findings related to race. However, my overarching research demonstrated that
high percentage of minorities negatively influenced provider effectiveness.
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Limitations
There are limitations to my study. First, I excluded new ACOs from the full
analysis. Thus, the range of performance of the sample population (n = 140) may not
reflect the distribution of the entire ACO base (n = 470). Nor may it reflect provider
patient relationships for providers and patients that do not participate in ACOs. Caution
should be used when generalizing these results for other applications. Second, the MSSP
PUF file data are restricted to the variables within the data set. The file does not provide
CRC screening results at the individual level for patients or providers. Thus, my findings
are limited to generalizations about ACOs based on total number of providers, total
number of patients, and percentages of patients with certain characteristics. As a result, I
am unable to articulate differences in ACO #19 compliance at the individual patient and
rely instead solely on the ACO #19 performance score. I am also unable to articulate
difference at the individual provider level. Lastly, the MSSP PUF has a one-year delay in
reporting. The results were provided before the significant change in care delivery due to
the COVID-19 pandemic and may influence the generalizability for future applications.
Implications
My study supported previous research that showed the characteristics of the
providers’ patient population affected their ability to influence patient behavior. It further
demonstrated disparities among poor patient populations. It also supports evidence which
suggested that lower socioeconomic patients and Medicaid patients experienced bias
when they pursued CRC screening (Davis et al., 2017). This may call for a focus on
cultural competency strategies to mediate intentional and unintended bias when working
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with patients from lower socioeconomic groups (Alspach, 2018). ACOs are partnerships
among care providers including public health organizations. Thus, ACOs should consider
their care delivery strategies and policies for lower socioeconomic populations as to the
eligibility for enrollment and the scope of benefits they receive.
My study promotes positive social change by providing meaningful data to the
public health and health care provider partnerships engaged in transforming healthcare
from a transactional delivery system to an evidence-based system of value (Berenson et
al., 2016). My study helps to decrease the prevalence of CRC and by doing so reduce the
economic and quality of life burden for individuals suffering from the disease. Moreover,
my study may help to reduce disparities for CRC screening and incidence of CRC among
poor populations. It provides a foundation for population health initiatives beyond CRC
related illness Thus, improving the wellbeing of communities and increase public health
emergency preparedness. Thus, my study can improve public health and healthcare
professionals’ ability to influence the behaviors and health outcomes of the community
members they serve. This is a vital component of current efforts to screen for COVID-19,
promote adoption of behaviors to slow the spread of COVID-19 and adoption of COVID19 vaccinations.
The CMS (2012) stated that more than 70% of patients over the age of 65 have
two or more chronic conditions. The management of patients with multiple chronic
diseases is more difficult than in those suffering from a single condition (Wagner et al.,
2013). Wang et al., observed (2020) that elderly COVID-19 patients were among the
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most severe to critical cases with a high rate of fatality. Thus, the results of my study
apply to current efforts for high risk elderly patients, their providers, and communities.
Cancer screening rates have declined due to the COVID-19 pandemic (Carethers
et al., 2020). The COVID-19 pandemic disproportionality affected poor and minority
communities (Carethers et al.). As such, Carethers et al., posit that extended delays in
cancer screening is expected to lead to increase cancer for all populations. This is
expected to be elevated in minorities and lower socio-economic people. My findings
offer insight as to which populations may be at greater risk based on their previous
experience with CRC screening before the pandemic.
Lastly, my study may offer guidance to public health and healthcare provider
leaders on ways to train professionals better, reduce frustration, improve success and
achieve higher levels of satisfaction in their work both in routine interventions and public
health emergencies.
Recommendations
Several recommendations resulted for additional research from my study.
Additional analysis should be conducted for further assessment of ACO #19 performance
based on additional patient characteristics such as age, race and gender. Second, CRC
screening is the most complex behavior measured for ACOs which include a variety of
tests with multiple steps like colonoscopy screening. This contrasts with dichotomous
behaviors like receiving a flu-vaccinations. I recommend future studies compare complex
behaviors like CRC with dichotomous decision like influenza vaccination.
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The study should also be replicated for all 470 ACO participants. This may
provide insight on differences and similarities to new and experienced ACOs. The study
should also include provider feedback using the Primary Care Provider Behavioral Health
Intervention Survey. The original tool was designed to assess provider perceptions of
factors that influence their intention to use interventions when treating children with
mental health problems and can be modified for adults (Arora et al., 2016).
Lastly the study should be replicated and expanded as a mixed methods
explanatory sequential study. Mixed methods integrates open-ended qualitative data with
closed-ended quantitative data from inquiry (Creswell, 2009). Mixed methods strategy is
purpose-driven research to provide a more in-depth insight into how health professionals
influence participant behavior (Creswell, 2009). Mixed methods can develop a more
comprehensive understanding of changes needed for population engagement as well as
understanding the process and outcomes of current patient engagement strategies
(Creswell, 2009).
Conclusion
Health care delivery and public health have overlapping efforts like health
screening activities for better health outcomes and to lower the burden of disease
(Cunningham, et al., 2020). Partnerships between community-based organizations, health
care delivery and public health organizations improve public health outcomes. Studies
showed patient behavior was the key to improve quality and health outcomes (Mogre et
al., 2019).
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The MSSP ACO is partnership based advanced payment model designed to curb
cost and improve patient outcomes for colon cancer among other disease measures. CRC
is a leading cause of death in the United States, (Loyd, 2016) and more research is needed
to determine the impact of MSSP ACO providers on CRC screening.
Previous research found disparities in health behavior recommendation
compliance among people based on insurance and socio-economic status. My
quantitative study of 140 ACO participants sought to determine the relationship between
Medicaid coverage and compliance with MSSP performance measure for colonoscopy
screening ACO #19.
My study supported previous research that showed the characteristics of the
providers’ patient population affected their ability to influence patient behavior. It further
demonstrated disparities among minority and poor patient populations. My study showed
differences in performance based on the number and percentage of patients with
Medicaid. Performance decreased as the number and percentage of patients increased.
This aligned with previous research which showed ACOs in underserved or lower socioeconomic areas did not perform as well as their peers in other areas.
My study addressed the gap in research and focused on the distribution of
Medicaid patients in ACO patient populations. It contributes to positive social change by
providing meaningful data to public health partnerships and policies that impact
community health outcomes for lower socio-economic patients. Therefore, the
application of my findings can improve the ability of public health and healthcare
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providers to predict their influence on behavior and health outcomes of the community
members they serve.
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Part 3: Summary
Integration of the Studies
My three studies incorporated different social determinants of health as
independent variables toward the same dependent variable—ACO success for CRC
screening. Collectively, these studies provide a picture of how ACO structures and the
characteristics of their attribution contribute to patient behavior. For instance, previous
researchers have found disparities in compliance among people with health behavior
recommendations based on age, race, gender, insurance coverage and the size of their
providers’ practices (Kiviniemi et al., 2018; Manteuffel et al., 2014). My results also
found disparities based on age, race, insurance coverage, and practice size as defined by
the number of patients. Additionally, the results showed that the number of providers
may not affect provider influence due to the collaborative nature of ACOs. Gender did
not influence performance in my study. However, the nature of my data was beyond
individual patients and warrants further exploration at the individual level. One
observation was that the number of patients in an ACO had a positive correlation to ACO
#19 performance. A quantitative follow up with primary care physicians may provide
more rationale for this phenomenon.
Broadly, the factors of my studies relate to the community and organizational
levels of the SEM. This is in part because the MSSP public use file provided attribution
level data rather than individual patient data. The policy level is nested in the rules and
guidelines of ACO formation, participation in the MSSP ACO program, and other
factors. As such, I recommend that future studies explore behavior and decision making
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at the individual level for patients and providers. This may provide more depth of
understanding of the provider and patient relationship. Furthermore, exploring the
specific strategies to influence behavior can also provide meaningful data for anyone
engaged in influencing behaviors related to public health. Provider experiences to engage
community members in their ACO attribution with varying social determinants of health
has not been fully explored. Thus, there is an inability to replicate best practices for
population engagement, which could improve health outcomes, participant experiences,
lower costs, and improve job satisfaction.
The social change contributions for my studies may offer meaningful data to
public health organization and health care provider partnerships. They may help decrease
the prevalence of CRC and by doing so reduce the economic and quality of life burden
for individuals suffering from the disease. Moreover, my studies may help to reduce
disparities for CRC screening, incidence of CRC, and other poor health outcomes among
vulnerable populations, thus improving the well-being of communities and increasing
public health emergency preparedness. My studies may also offer guidance to both public
health and healthcare provider leaders on ways to train professionals better, reduce
frustration, improve success, and achieve higher levels of satisfaction in their work both
in routine interventions and public health emergencies.
Conclusion
Health care delivery and public health have overlapping efforts like health
screening activities for better health outcomes and lowering the burden of disease
(Cunningham et al., 2020). Partnerships between community-based organizations, health
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care delivery, and public health organizations improve public health outcomes. The
MSSP ACO is a partnership-based advanced payment model designed to curb cost and
improve patient outcomes for colon cancer among other disease measures. However,
more research is needed to determine the impact of MSSP ACO providers on CRC
screening. Additionally, studies have also shown that patient behavior is the key to
improve quality and health outcomes (Mogre et al., 2019).
My quantitative study of 140 ACO participants sought to determine the
relationship between patient attribution and provider characteristics with performance
measure for colonoscopy screening ACO #19 compliance. My findings correlate with
previous research. My results showed that the number of primary care physicians in an
ACO did not influence their ACO #19 score. Thus, primary care provider participation
and collaboratoin in an ACO may mediate some of the contraints found in other studies
on practice size and ACO performance. I found that ACOs with more patients performed
better. However, performance declined as the number and percentage of non-White
patients increased. This aligned with previous research that showed disparities across
socioeconomic and racial/ethnic groups. I found further differences in performance based
on age. Performance increased for ACOs with more patients between the age of 65-85
years old and declined with higher numbers of patients below 65 years old and over 85.
My study also found that performance decreased as the number and percentage of
Medicaid patients increased. This aligned with previous research that showed ACOs in
underserved or lower socioeconomic areas did not perform as well as their peers in other
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areas. My results did not show a difference in performance based on the gender of the
ACO population.
My study addressed the gap in research and focused on providers’ abilities to
influence APM participant behavior. The research contributes to positive social change
by providing meaningful data to public health partnerships that impact community health
outcomes. Thus, the application of my findings can improve the ability of public health
and healthcare providers to influence the behaviors and health outcomes of the
community members they serve.
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